{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:50:31Z","timestamp":1791575431392,"version":"4.3.4"},"reference-count":262,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yunnan Province Major Science and Technology Project","award":["202402AD080006"],"award-info":[{"award-number":["202402AD080006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"DOI":"10.1186\/s40364-026-01014-x","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:43:14Z","timestamp":1791528194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RNA N4-acetylcytidine modification in health and cancer: molecular mechanisms, cellular plasticity, and therapeutic opportunities"],"prefix":"10.1186","volume":"14","author":[{"given":"Xiao-Yan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofu","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunze","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"1014_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41392-023-01638-7","volume":"8","author":"C Wang","year":"2023","unstructured":"Wang C, Hou X, Guan Q, Zhou H, Zhou L, Liu L, Liu J, Li F, Li W, Liu H. RNA modification in cardiovascular disease: implications for therapeutic interventions. Signal Transduct Target Ther. 2023;8:412.","journal-title":"Signal Transduct Target Ther"},{"key":"1014_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41573-025-01280-8","volume":"25","author":"L Zhang","year":"2026","unstructured":"Zhang L, Wei J, Zou Z, He C. RNA modification systems as therapeutic targets. Nat Rev Drug Discov. 2026;25:59\u201378.","journal-title":"Nat Rev Drug Discov"},{"key":"1014_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev-immunol-101921-045401","volume":"41","author":"D Han","year":"2023","unstructured":"Han D, Xu MM. RNA Modification in the Immune System. Annu Rev Immunol. 2023;41:73\u201398.","journal-title":"Annu Rev Immunol"},{"key":"1014_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/15476286.2023.2246256","volume":"20","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Hu W, Li HB. RNA modification-mediated translational control in immune cells. RNA Biol. 2023;20:603\u201313.","journal-title":"RNA Biol"},{"key":"1014_CR5","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","volume":"169","author":"IA Roundtree","year":"2017","unstructured":"Roundtree IA, Evans ME, Pan T, He C. Dynamic RNA Modifications in Gene Expression Regulation. Cell. 2017;169:1187\u2013200.","journal-title":"Cell"},{"key":"1014_CR6","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.aau1646","volume":"361","author":"M Frye","year":"2018","unstructured":"Frye M, Harada BT, Behm M, He C. RNA modifications modulate gene expression during development. Science. 2018;361:1346\u20139.","journal-title":"Science"},{"key":"1014_CR7","doi-asserted-by":"publisher","first-page":"e105977","DOI":"10.15252\/embj.2020105977","volume":"40","author":"PC He","year":"2021","unstructured":"He PC, He C. m(6) A RNA methylation: from mechanisms to therapeutic potential. Embo j. 2021;40:e105977.","journal-title":"Embo j"},{"key":"1014_CR8","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","volume":"74","author":"H Shi","year":"2019","unstructured":"Shi H, Wei J, He C. Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers. Mol Cell. 2019;74:640\u201350.","journal-title":"Mol Cell"},{"key":"1014_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.omtn.2023.03.023","volume":"32","author":"L Xie","year":"2023","unstructured":"Xie L, Zhong X, Cao W, Liu J, Zu X, Chen L. Mechanisms of NAT10 as ac4C writer in diseases. Mol Ther Nucleic Acids. 2023;32:359\u201368.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1014_CR10","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1186\/s12967-025-06985-3","volume":"23","author":"J Wang","year":"2025","unstructured":"Wang J, Qi C, Wang R, Cao Y, Zhou Y, Ye G. m5C RNA modification in colorectal cancer: mechanisms and therapeutic targets. J Transl Med. 2025;23:948.","journal-title":"J Transl Med"},{"key":"1014_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, Yang C, Chen Y. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.","journal-title":"Signal Transduct Target Ther"},{"key":"1014_CR12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12943-024-02148-y","volume":"23","author":"Y Qiu","year":"2024","unstructured":"Qiu Y, Man C, Zhu L, Zhang S, Wang X, Gong D, Fan Y. R-loops\u2019 m6A modification and its roles in cancers. Mol Cancer. 2024;23:232.","journal-title":"Mol Cancer"},{"key":"1014_CR13","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3892\/ijmm.2020.4746","volume":"46","author":"Y Qin","year":"2020","unstructured":"Qin Y, Li L, Luo E, Hou J, Yan G, Wang D, Qiao Y, Tang C. Role of m6A RNA methylation in cardiovascular disease (Review). Int J Mol Med. 2020;46:1958\u201372.","journal-title":"Int J Mol Med"},{"key":"1014_CR14","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1002\/jcp.30828","volume":"237","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu N. N6-methyladenosine (m6A) modification in gynecological malignancies. J Cell Physiol. 2022;237:3465\u201379.","journal-title":"J Cell Physiol"},{"key":"1014_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12964-023-01078-4","volume":"21","author":"E Huang","year":"2023","unstructured":"Huang E, Chen L. RNA N(6)-methyladenosine modification in female reproductive biology and pathophysiology. Cell Commun Signal. 2023;21:53.","journal-title":"Cell Commun Signal"},{"key":"1014_CR16","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1093\/plphys\/kiad625","volume":"194","author":"JH Luo","year":"2024","unstructured":"Luo JH, Guo T, Wang M, Liu JH, Zheng LM, He Y. RNA m6A modification facilitates DNA methylation during maize kernel development. Plant Physiol. 2024;194:2165\u201382.","journal-title":"Plant Physiol"},{"key":"1014_CR17","doi-asserted-by":"publisher","first-page":"e1510","DOI":"10.1002\/wrna.1510","volume":"10","author":"L Trixl","year":"2019","unstructured":"Trixl L, Lusser A. The dynamic RNA modification 5-methylcytosine and its emerging role as an epitranscriptomic mark. Wiley Interdiscip Rev RNA. 2019;10:e1510.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"1014_CR18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/eurheartj\/ehae707","volume":"46","author":"C Yu","year":"2025","unstructured":"Yu C, Chen Y, Luo H, Lin W, Lin X, Jiang Q, Liu H, Liu W, Yang J, Huang Y, et al. NAT10 promotes vascular remodelling via mRNA ac4C acetylation. Eur Heart J. 2025;46:288\u2013304.","journal-title":"Eur Heart J"},{"key":"1014_CR19","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1161\/CIRCRESAHA.122.322244","volume":"133","author":"J Shi","year":"2023","unstructured":"Shi J, Yang C, Zhang J, Zhao K, Li P, Kong C, Wu X, Sun H, Zheng R, Sun W, et al. NAT10 Is Involved in Cardiac Remodeling Through ac4C-Mediated Transcriptomic Regulation. Circ Res. 2023;133:989\u20131002.","journal-title":"Circ Res"},{"key":"1014_CR20","doi-asserted-by":"crossref","unstructured":"Gu Z, Zou L, Pan X, Yu Y, Liu Y, Zhang Z, Liu J, Mao S, Zhang J, Guo C, et al. The role and mechanism of NAT10-mediated ac4C modification in tumor development and progression. MedComm (2020). 2024;5:e70026.","DOI":"10.1002\/mco2.70026"},{"key":"1014_CR21","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1016\/j.molcel.2022.05.016","volume":"82","author":"D Arango","year":"2022","unstructured":"Arango D, Sturgill D, Yang R, Kanai T, Bauer P, Roy J, Wang Z, Hosogane M, Schiffers S, Oberdoerffer S. Direct epitranscriptomic regulation of mammalian translation initiation through N4-acetylcytidine. Mol Cell. 2022;82:2797\u2013e28142711.","journal-title":"Mol Cell"},{"key":"1014_CR22","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/s41418-025-01483-x","volume":"32","author":"X Wan","year":"2025","unstructured":"Wan X, Wang L, Khan MA, Peng L, Sun X, Yi X, Wang Z, Chen K. NAT10-mediated N4-acetylcytidine modification in KLF9 mRNA promotes adipogenesis. Cell Death Differ. 2025;32:1613\u201329.","journal-title":"Cell Death Differ"},{"key":"1014_CR23","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41586-020-2418-2","volume":"583","author":"A Sas-Chen","year":"2020","unstructured":"Sas-Chen A, Thomas JM, Matzov D, Taoka M, Nance KD, Nir R, Bryson KM, Shachar R, Liman GLS, Burkhart BW, et al. Dynamic RNA acetylation revealed by quantitative cross-evolutionary mapping. Nature. 2020;583:638\u201343.","journal-title":"Nature"},{"key":"1014_CR24","doi-asserted-by":"crossref","unstructured":"Zhou M, Thalalla Gamage S, Tran KA, Bartee D, Wei X, Yin B, Berger S, Meier JL, Marmorstein R. Structure of the NAT10 acetyltransferase and mechanism of tRNA acetylation. Nat Commun. 2026;17.","DOI":"10.1038\/s41467-026-74222-6"},{"key":"1014_CR25","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/jjco\/hyag018","volume":"56","author":"BY Yu","year":"2026","unstructured":"Yu BY, Ueda H. RNA modifications in cancer and their detection: a review. Jpn J Clin Oncol. 2026;56:518\u201337.","journal-title":"Jpn J Clin Oncol"},{"key":"1014_CR26","doi-asserted-by":"publisher","first-page":"102207","DOI":"10.1016\/j.gde.2024.102207","volume":"87","author":"C Achour","year":"2024","unstructured":"Achour C, Oberdoerffer S. NAT10 and cytidine acetylation in mRNA: intersecting paths in development and disease. Curr Opin Genet Dev. 2024;87:102207.","journal-title":"Curr Opin Genet Dev"},{"key":"1014_CR27","first-page":"1582","volume":"28","author":"S Thalalla Gamage","year":"2022","unstructured":"Thalalla Gamage S, Bortolin-Cavaill\u00e9 ML, Link C, Bryson K, Sas-Chen A, Schwartz S, Cavaill\u00e9 J, Meier JL. Antisense pairing and SNORD13 structure guide RNA cytidine acetylation. RNA. 2022;28:1582\u201396.","journal-title":"RNA"},{"key":"1014_CR28","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1021\/jacs.1c11985","volume":"144","author":"D Bartee","year":"2022","unstructured":"Bartee D, Nance KD, Meier JL. Site-Specific Synthesis of N(4)-Acetylcytidine in RNA Reveals Physiological Duplex Stabilization. J Am Chem Soc. 2022;144:3487\u201396.","journal-title":"J Am Chem Soc"},{"key":"1014_CR29","doi-asserted-by":"publisher","first-page":"1133166","DOI":"10.3389\/fimmu.2023.1133166","volume":"14","author":"D Xu","year":"2023","unstructured":"Xu D, Huang K, Chen Y, Yang F, Xia C, Yang H. Immune response and drug therapy based on ac4C-modified gene in pancreatic cancer typing. Front Immunol. 2023;14:1133166.","journal-title":"Front Immunol"},{"key":"1014_CR30","doi-asserted-by":"publisher","first-page":"e2411834","DOI":"10.1002\/advs.202411834","volume":"12","author":"H Wang","year":"2025","unstructured":"Wang H, Zhao B, Zhang J, Hu Q, Zhou L, Zhang Y, Cai Y, Qu Y, Jiang T, Zhang D. N4-Acetylcytidine-Mediated CD2BP2-DT Drives YBX1 Phase Separation to Stabilize CDK1 and Promote Breast Cancer Progression. Adv Sci (Weinh). 2025;12:e2411834.","journal-title":"Adv Sci (Weinh)"},{"key":"1014_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00018-023-05107-w","volume":"81","author":"H Zhang","year":"2024","unstructured":"Zhang H, Lu R, Huang J, Li L, Cao Y, Huang C, Chen R, Wang Y, Huang J, Zhao X, Yu J. N4-acetylcytidine modifies primary microRNAs for processing in cancer cells. Cell Mol Life Sci. 2024;81:73.","journal-title":"Cell Mol Life Sci"},{"key":"1014_CR32","doi-asserted-by":"crossref","unstructured":"Zhang J, Shi H, Wang C, Liu Z, Zhou L, Lv X, Guo M, Yang Y, Gu C. NAT10-mediated ac4C modification of circANKRD12 reprograms the tumor microenvironment. Adv Sci (Weinh). 2026:e75797.","DOI":"10.1002\/advs.75797"},{"key":"1014_CR33","doi-asserted-by":"crossref","unstructured":"Furuse Y. RNA modifications in genomic RNA of influenza A virus and the relationship between RNA modifications and viral infection. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms22179127"},{"key":"1014_CR34","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.cell.2018.10.030","volume":"175","author":"D Arango","year":"2018","unstructured":"Arango D, Sturgill D, Alhusaini N, Dillman AA, Sweet TJ, Hanson G, Hosogane M, Sinclair WR, Nanan KK, Mandler MD, et al. Acetylation of Cytidine in mRNA Promotes Translation Efficiency. Cell. 2018;175:1872\u2013e18861824.","journal-title":"Cell"},{"key":"1014_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s43556-023-00139-x","volume":"4","author":"L Qiu","year":"2023","unstructured":"Qiu L, Jing Q, Li Y, Han J. RNA modification: mechanisms and therapeutic targets. Mol Biomed. 2023;4:25.","journal-title":"Mol Biomed"},{"key":"1014_CR36","doi-asserted-by":"publisher","first-page":"106017","DOI":"10.1016\/j.neuint.2025.106017","volume":"188","author":"ZH Zeng","year":"2025","unstructured":"Zeng ZH, Zhang LX, Li MQ, Wang XQ, Zou GJ, Yao JY, Li CQ, Cui YH, Li F. N-acetyltransferase 10 in the nucleus accumbens participates in methamphetamine-induced conditioned place preference and hyperlocomotion in mice. Neurochem Int. 2025;188:106017.","journal-title":"Neurochem Int"},{"key":"1014_CR37","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1111\/cas.15946","volume":"114","author":"Y Liu","year":"2023","unstructured":"Liu Y, Huang H, Zhang CB, Fan HN. N-acetyltransferase 10 promotes the progression of oral squamous cell carcinoma through N4-acetylcytidine RNA acetylation of MMP1 mRNA. Cancer Sci. 2023;114:4202\u201315.","journal-title":"Cancer Sci"},{"key":"1014_CR38","doi-asserted-by":"publisher","first-page":"e2410263","DOI":"10.1002\/advs.202410263","volume":"12","author":"C Chen","year":"2025","unstructured":"Chen C, Wang Z, Lin Q, Li M, Xu L, Fu Y, Zhao X, Ma Z, Xu J, Zhou S, et al. NAT10 Promotes Gastric Cancer Liver Metastasis by Modulation of M2 Macrophage Polarization and Metastatic Tumor Cell Hepatic Adhesion. Adv Sci (Weinh). 2025;12:e2410263.","journal-title":"Adv Sci (Weinh)"},{"key":"1014_CR39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13046-022-02551-7","volume":"41","author":"C Jin","year":"2022","unstructured":"Jin C, Wang T, Zhang D, Yang P, Zhang C, Peng W, Jin K, Wang L, Zhou J, Peng C, et al. Acetyltransferase NAT10 regulates the Wnt\/\u03b2-catenin signaling pathway to promote colorectal cancer progression via ac(4)C acetylation of KIF23 mRNA. J Exp Clin Cancer Res. 2022;41:345.","journal-title":"J Exp Clin Cancer Res"},{"key":"1014_CR40","doi-asserted-by":"publisher","first-page":"103145","DOI":"10.1016\/j.redox.2024.103145","volume":"72","author":"Z Qu","year":"2024","unstructured":"Qu Z, Pang X, Mei Z, Li Y, Zhang Y, Huang C, Liu K, Yu S, Wang C, Sun Z, et al. The positive feedback loop of the NAT10\/Mybbp1a\/p53 axis promotes cardiomyocyte ferroptosis to exacerbate cardiac I\/R injury. Redox Biol. 2024;72:103145.","journal-title":"Redox Biol"},{"key":"1014_CR41","doi-asserted-by":"crossref","unstructured":"Xie H, Zhang K, Yin H, Zhang S, Pan S, Wu R, Han Y, Xu Y, Jiang W, You B. Acetyltransferase NAT10 inhibits T-cell immunity and promotes nasopharyngeal carcinoma progression through DDX5\/HMGB1 axis. J Immunother Cancer. 2025;13.","DOI":"10.1136\/jitc-2024-010301"},{"key":"1014_CR42","doi-asserted-by":"publisher","first-page":"e2400133","DOI":"10.1002\/advs.202400133","volume":"11","author":"ZY Jiang","year":"2024","unstructured":"Jiang ZY, Wu YK, Deng ZQ, Chen L, Zhu YM, Yu YS, Wu HB, Fan HY. PCBP1\/2 and TDP43 Function as NAT10 Adaptors to Mediate mRNA ac(4)C Formation in Mammalian Cells. Adv Sci (Weinh). 2024;11:e2400133.","journal-title":"Adv Sci (Weinh)"},{"key":"1014_CR43","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1136\/ard-2023-225343","volume":"83","author":"D Liu","year":"2024","unstructured":"Liu D, Kuang Y, Chen S, Li R, Su F, Zhang S, Qiu Q, Lin S, Shen C, Liu Y, et al. NAT10 promotes synovial aggression by increasing the stability and translation of N4-acetylated PTX3 mRNA in rheumatoid arthritis. Ann Rheum Dis. 2024;83:1118\u201331.","journal-title":"Ann Rheum Dis"},{"key":"1014_CR44","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/cac2.70045","volume":"45","author":"E Chen","year":"2025","unstructured":"Chen E, Wang Q, Wang L, Huang Z, Yang D, Zhao C, Chen W, Zhang S, Xiong S, He Y, et al. NAT10 regulates tumor progression and immune microenvironment in pancreatic ductal adenocarcinoma via the N4-acetylated LAMB3-mediated FAK\/ERK pathway. Cancer Commun (Lond). 2025;45:1162\u201387.","journal-title":"Cancer Commun (Lond)"},{"key":"1014_CR45","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1038\/s44319-025-00509-2","volume":"26","author":"WJ Jiang","year":"2025","unstructured":"Jiang WJ, Mao XT, Li WP, Jin N, Wang Y, Guan G, Jin J, Li YY. NAT10-mediated acetylation of NIK mRNA in B cells promotes IgA production. EMBO Rep. 2025;26:3917\u201336.","journal-title":"EMBO Rep"},{"key":"1014_CR46","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s12944-024-02360-1","volume":"23","author":"Z Wang","year":"2024","unstructured":"Wang Z, Wan X, Khan MA, Peng L, Sun X, Yi X, Chen K. NAT10 promotes liver lipogenesis in mouse through N4-acetylcytidine modification of Srebf1 and Scap mRNA. Lipids Health Dis. 2024;23:368.","journal-title":"Lipids Health Dis"},{"key":"1014_CR47","first-page":"20250075","volume":"5","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Dong Y, Chen S, Deng H, Yu W, Chen B, Chen M, Liu W, Tan X, Ni J, et al. Targeting NAT10 Inhibits Hepatocarcinogenesis via ac4C-Mediated SMAD3 mRNA Stability. Explor (Beijing). 2025;5:20250075.","journal-title":"Explor (Beijing)"},{"key":"1014_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12964-023-01321-y","volume":"22","author":"Z Mei","year":"2024","unstructured":"Mei Z, Shen Z, Pu J, Liu Q, Liu G, He X, Wang Y, Yue J, Ge S, Li T, et al. NAT10 mediated ac4C acetylation driven m(6)A modification via involvement of YTHDC1-LDHA\/PFKM regulates glycolysis and promotes osteosarcoma. Cell Commun Signal. 2024;22:51.","journal-title":"Cell Commun Signal"},{"key":"1014_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s43556-024-00228-5","volume":"5","author":"J Liu","year":"2024","unstructured":"Liu J, Gu Z, Zou L, Zhang Z, Shen L, Wang R, Xue S, Geng J, Mao S, Zhang W, Yao X. Acetyltransferase NAT10 promotes an immunosuppressive microenvironment by modulating CD8(+) T cell activity in prostate cancer. Mol Biomed. 2024;5:67.","journal-title":"Mol Biomed"},{"key":"1014_CR50","doi-asserted-by":"publisher","first-page":"eady0301","DOI":"10.1126\/sciadv.ady0301","volume":"12","author":"F Huang","year":"2026","unstructured":"Huang F, Wang Y, Gao W, Zhang X, Zhou J, Yang Y, Mo H, Wang M, Chen Q, Peng G, et al. Nat10-mediated ac4C epitranscriptomics orchestrates hematopoietic stem\/progenitor cell fate determination via translation control. Sci Adv. 2026;12:eady0301.","journal-title":"Sci Adv"},{"key":"1014_CR51","doi-asserted-by":"crossref","unstructured":"Wang Q, Yuan Y, Zhou Q, Jia Y, Liu J, Xiao G, Li C, Jiang X. RNA N4-acetylcytidine modification and its role in health and diseases. MedComm (2020). 2025;6:e70015.","DOI":"10.1002\/mco2.70015"},{"key":"1014_CR52","doi-asserted-by":"publisher","first-page":"e13577","DOI":"10.1111\/cpr.13577","volume":"57","author":"J Ge","year":"2024","unstructured":"Ge J, Wang Z, Wu J. NAT10-mediated ac(4)C modification promotes ectoderm differentiation of human embryonic stem cells via acetylating NR2F1 mRNA. Cell Prolif. 2024;57:e13577.","journal-title":"Cell Prolif"},{"key":"1014_CR53","doi-asserted-by":"publisher","first-page":"1795359","DOI":"10.3389\/fcell.2026.1795359","volume":"14","author":"J Xiong","year":"2026","unstructured":"Xiong J, Yuan Y, Li C, Zhou Q, Jiang L, Jiang X, Lin Y. Functional roles and mechanisms of NAT10-mediated RNA ac(4)C modification in normal development and cancer progression. Front Cell Dev Biol. 2026;14:1795359.","journal-title":"Front Cell Dev Biol"},{"key":"1014_CR54","doi-asserted-by":"publisher","first-page":"5154","DOI":"10.1038\/s41467-025-60293-4","volume":"16","author":"WC Liu","year":"2025","unstructured":"Liu WC, Wei YH, Chen JF, Xing XL, Jia HX, Yang XY, Huang YJ, Liu XM, Xiao K, Guo XD, et al. Inhibition of tumor-intrinsic NAT10 enhances antitumor immunity by triggering type I interferon response via MYC\/CDK2\/DNMT1 pathway. Nat Commun. 2025;16:5154.","journal-title":"Nat Commun"},{"key":"1014_CR55","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12032-022-01736-6","volume":"39","author":"Z Wang","year":"2022","unstructured":"Wang Z, Huang Y, Lu W, Liu J, Li X, Zhu S, Liu H, Song Y. c-myc-mediated upregulation of NAT10 facilitates tumor development via cell cycle regulation in non-small cell lung cancer. Med Oncol. 2022;39:140.","journal-title":"Med Oncol"},{"key":"1014_CR56","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41590-025-02100-2","volume":"26","author":"L Sun","year":"2025","unstructured":"Sun L, Li X, Xu F, Chen Y, Li X, Yang Z, Yang Y, Wang K, Ren T, Lin Z, et al. A critical role of N(4)-acetylation of cytidine in mRNA by NAT10 in T cell expansion and antiviral immunity. Nat Immunol. 2025;26:619\u201334.","journal-title":"Nat Immunol"},{"key":"1014_CR57","doi-asserted-by":"crossref","unstructured":"Wei B, Zhao H, Chang S, Wang W. The NAT10\/c-Myc positive feedback loop orchestrates tRNA ac(4)C modification and OTUB1-mediated protein stabilization to drive anaplastic thyroid carcinoma progression. Cell Mol Biol Lett. 2026.","DOI":"10.1186\/s11658-026-00977-x"},{"key":"1014_CR58","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41388-025-03661-0","volume":"45","author":"H Wang","year":"2026","unstructured":"Wang H, Ge L, Li J, Zhong K, Li S, Ma N, Tao L, Zhou J, Wang Z, Chang X, et al. NAT10 triggers colorectal cancer progression via promoting PPAN-regulated DNA damage repair. Oncogene. 2026;45:558\u201376.","journal-title":"Oncogene"},{"key":"1014_CR59","doi-asserted-by":"publisher","first-page":"154990","DOI":"10.1016\/j.prp.2023.154990","volume":"253","author":"P Rodrigues","year":"2024","unstructured":"Rodrigues P, Bangali H, Ali E, Nauryzbaevish AS, Hjazi A, Fenjan MN, Alawadi A, Alsaalamy A, Alasheqi MQ, Mustafa YF. The mechanistic role of NAT10 in cancer: Unraveling the enigmatic web of oncogenic signaling. Pathol Res Pract. 2024;253:154990.","journal-title":"Pathol Res Pract"},{"key":"1014_CR60","doi-asserted-by":"publisher","first-page":"eads6144","DOI":"10.1126\/sciadv.ads6144","volume":"11","author":"TK Debnath","year":"2025","unstructured":"Debnath TK, Abell NS, Li YR, Devanathan SK, Navedo E, Xhemal\u00e7e B. NAT10 and N(4)-acetylcytidine restrain R-loop levels and related inflammatory responses. Sci Adv. 2025;11:eads6144.","journal-title":"Sci Adv"},{"key":"1014_CR61","doi-asserted-by":"publisher","first-page":"117408","DOI":"10.1016\/j.celrep.2026.117408","volume":"45","author":"X Wu","year":"2026","unstructured":"Wu X, Wang D, Taori S, Wu W, Dixit D, Lv D, Mullett SJ, Gelhaus SL, Yuan F, Zhang P, et al. NAT10-dependent N(4)-acetylcytidine reprograms R-loops and promotes cancer stem cell growth. Cell Rep. 2026;45:117408.","journal-title":"Cell Rep"},{"key":"1014_CR62","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41422-023-00793-4","volume":"33","author":"L Liao","year":"2023","unstructured":"Liao L, He Y, Li SJ, Yu XM, Liu ZC, Liang YY, Yang H, Yang J, Zhang GG, Deng CM, et al. Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner. Cell Res. 2023;33:355\u201371.","journal-title":"Cell Res"},{"key":"1014_CR63","doi-asserted-by":"crossref","unstructured":"Shang C, Wang X, Huang Y, Zhu J, Liu X, Zhang H, Guan W, Hao H, Zhang F. The NAT10\/ac(4)C axis: a central nexus linking RNA acetylation to immunometabolic signaling in disease. Cell Commun Signal. 2026;24.","DOI":"10.1186\/s12964-026-02768-5"},{"key":"1014_CR64","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1021\/acsmedchemlett.0c00193","volume":"12","author":"JH Shrimp","year":"2021","unstructured":"Shrimp JH, Jing Y, Gamage ST, Nelson KM, Han J, Bryson KM, Montgomery DC, Thomas JM, Nance KD, Sharma S, et al. Remodelin Is a Cryptic Assay Interference Chemotype That Does Not Inhibit NAT10-Dependent Cytidine Acetylation. ACS Med Chem Lett. 2021;12:887\u201392.","journal-title":"ACS Med Chem Lett"},{"key":"1014_CR65","doi-asserted-by":"publisher","first-page":"126837","DOI":"10.1016\/j.ijbiomac.2023.126837","volume":"253","author":"FL Lai","year":"2023","unstructured":"Lai FL, Gao F. LSA-ac4C: A hybrid neural network incorporating double-layer LSTM and self-attention mechanism for the prediction of N4-acetylcytidine sites in human mRNA. Int J Biol Macromol. 2023;253:126837.","journal-title":"Int J Biol Macromol"},{"key":"1014_CR66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/09645284221085284","volume":"41","author":"Z Geng","year":"2023","unstructured":"Geng Z, Liu P, Yuan L, Zhang K, Lin J, Nie X, Jiang H, Li B, Liu T, Zhang B. Electroacupuncture attenuates ac4C modification of P16 mRNA in the ovarian granulosa cells of a mouse model premature ovarian failure. Acupunct Med. 2023;41:27\u201337.","journal-title":"Acupunct Med"},{"key":"1014_CR67","doi-asserted-by":"publisher","first-page":"115428","DOI":"10.1016\/j.celrep.2025.115428","volume":"44","author":"L Cai","year":"2025","unstructured":"Cai L, Li B, Zhou Q, Du J, Yang W, Shen L, He C. N-acetyltransferase 10 catalyzes RNA N(4)-acetylcytidine to regulate photosynthesis in rice. Cell Rep. 2025;44:115428.","journal-title":"Cell Rep"},{"key":"1014_CR68","doi-asserted-by":"publisher","first-page":"44643","DOI":"10.31083\/JIN44643","volume":"24","author":"Y Li","year":"2025","unstructured":"Li Y, Gao J, Xiao Y, Huang T. Deciphering the Role of N-Acetyltransferase 10 in Thalamic Hemorrhage Through Integrative Multi-Omics and Experimental Validation. J Integr Neurosci. 2025;24:44643.","journal-title":"J Integr Neurosci"},{"key":"1014_CR69","doi-asserted-by":"publisher","first-page":"eads2923","DOI":"10.1126\/sciadv.ads2923","volume":"11","author":"S Thalalla Gamage","year":"2025","unstructured":"Thalalla Gamage S, Khoogar R, Howpay Manage S, DaRos JT, Crawford MC, Georgeson J, Polevoda BV, Sanders C, Lee KA, Nance KD, et al. Transfer RNA acetylation regulates in vivo mammalian stress signaling. Sci Adv. 2025;11:eads2923.","journal-title":"Sci Adv"},{"key":"1014_CR70","doi-asserted-by":"crossref","unstructured":"Sleiman S, Dragon F. Recent advances on the structure and function of RNA Acetyltransferase Kre33\/NAT10. Cells. 2019;8.","DOI":"10.3390\/cells8091035"},{"key":"1014_CR71","doi-asserted-by":"publisher","first-page":"115628","DOI":"10.1016\/j.bcp.2023.115628","volume":"213","author":"J Luo","year":"2023","unstructured":"Luo J, Cao J, Chen C, Xie H. Emerging role of RNA acetylation modification ac4C in diseases: Current advances and future challenges. Biochem Pharmacol. 2023;213:115628.","journal-title":"Biochem Pharmacol"},{"key":"1014_CR72","doi-asserted-by":"publisher","first-page":"e70227","DOI":"10.1002\/jbt.70227","volume":"39","author":"J Liang","year":"2025","unstructured":"Liang J, Zhai P, Cheng G, Han J, Song X. N-Acetyltransferase 10 Promotes Gastric Cancer Progression by Mediating the N4-Acetylcytidine Modification of Lactate Dehydrogenase A. J Biochem Mol Toxicol. 2025;39:e70227.","journal-title":"J Biochem Mol Toxicol"},{"key":"1014_CR73","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s10020-024-00912-w","volume":"30","author":"P Xing","year":"2024","unstructured":"Xing P, Zhou M, Sun J, Wang D, Huang W, An P. NAT10-mediated ac(4)C acetylation of TFRC promotes sepsis-induced pulmonary injury through regulating ferroptosis. Mol Med. 2024;30:140.","journal-title":"Mol Med"},{"key":"1014_CR74","doi-asserted-by":"publisher","first-page":"e1747","DOI":"10.1002\/ctm2.1747","volume":"14","author":"M Ding","year":"2024","unstructured":"Ding M, Yu Z, Lu T, Hu S, Zhou X, Wang X. N-acetyltransferase 10 facilitates tumorigenesis of diffuse large B-cell lymphoma by regulating AMPK\/mTOR signalling through N4-acetylcytidine modification of SLC30A9. Clin Transl Med. 2024;14:e1747.","journal-title":"Clin Transl Med"},{"key":"1014_CR75","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1016\/j.apsb.2025.03.042","volume":"15","author":"L Yang","year":"2025","unstructured":"Yang L, Li X, Zhao Y, Chen H, Wang C, Wu A, Guo X, Huang Y, Wang Q, Hao L, et al. NAT10 inhibition alleviates astrocyte autophagy by impeding ac4C acetylation of Timp1 mRNA in ischemic stroke. Acta Pharm Sin B. 2025;15:2575\u201392.","journal-title":"Acta Pharm Sin B"},{"key":"1014_CR76","doi-asserted-by":"publisher","first-page":"112810","DOI":"10.1016\/j.celrep.2023.112810","volume":"42","author":"W Wei","year":"2023","unstructured":"Wei W, Zhang S, Han H, Wang X, Zheng S, Wang Z, Yang C, Wang L, Ma J, Guo S, et al. NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer. Cell Rep. 2023;42:112810.","journal-title":"Cell Rep"},{"key":"1014_CR77","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41368-023-00276-7","volume":"16","author":"X Wang","year":"2024","unstructured":"Wang X, Ling R, Peng Y, Qiu W, Chen D. RNPS1 stabilizes NAT10 protein to facilitate translation in cancer via tRNA ac(4)C modification. Int J Oral Sci. 2024;16:6.","journal-title":"Int J Oral Sci"},{"key":"1014_CR78","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/s41418-024-01327-0","volume":"31","author":"Q Yan","year":"2024","unstructured":"Yan Q, Zhou J, Gu Y, Huang W, Ruan M, Zhang H, Wang T, Wei P, Chen G, Li W, Lu C. Lactylation of NAT10 promotes N(4)-acetylcytidine modification on tRNA(Ser-CGA-1-1) to boost oncogenic DNA virus KSHV reactivation. Cell Death Differ. 2024;31:1362\u201374.","journal-title":"Cell Death Differ"},{"key":"1014_CR79","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.1016\/j.molcel.2025.11.010","volume":"85","author":"R Amin","year":"2025","unstructured":"Amin R, Ha NH, Qiu T, Holewinski R, Lam KC, Daugherty-Lop\u00e8s A, Liu H, Tran AD, Lee MP, Andresson T, et al. NAT10 promotes cancer metastasis by modulating p300\/CBP activity through chromatin-associated tRNA. Mol Cell. 2025;85:4526\u2013e45444518.","journal-title":"Mol Cell"},{"key":"1014_CR80","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1038\/s41388-024-03133-x","volume":"43","author":"S Gong","year":"2024","unstructured":"Gong S, Qiao H, Wang JY, Huang SY, He SW, Zhao Y, Tan XR, Ye ML, Li JY, Liang YL, et al. Ac4C modification of lncRNA SIMALR promotes nasopharyngeal carcinoma progression through activating eEF1A2 to facilitate ITGB4\/ITGA6 translation. Oncogene. 2024;43:2868\u201384.","journal-title":"Oncogene"},{"key":"1014_CR81","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/s41388-023-02628-3","volume":"42","author":"XM Yu","year":"2023","unstructured":"Yu XM, Li SJ, Yao ZT, Xu JJ, Zheng CC, Liu ZC, Ding PB, Jiang ZL, Wei X, Zhao LP, et al. N4-acetylcytidine modification of lncRNA CTC-490G23.2 promotes cancer metastasis through interacting with PTBP1 to increase CD44 alternative splicing. Oncogene. 2023;42:1101\u201316.","journal-title":"Oncogene"},{"key":"1014_CR82","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.7150\/ijbs.113325","volume":"21","author":"X Lei","year":"2025","unstructured":"Lei X, Zheng B, Peng Y, Zhang G, Cheng X, Li W, He J, Li F, Ling R, Fu Z, et al. Targeting the NAT10\/XIST\/YAP1 Axis-Mediated Vascular Abnormalization Enhances Immune Checkpoint Blockade in Gastric Cancer. Int J Biol Sci. 2025;21:4997\u20135014.","journal-title":"Int J Biol Sci"},{"key":"1014_CR83","doi-asserted-by":"crossref","unstructured":"Zhang X, Qin S, Huang F, Liu H, Wang J, Chen Z, Hao H, Ding S, Liu L, Yu B, et al. N4-acetylcytidine coordinates with NP1 and CPSF5 to facilitate alternative RNA processing during the replication of minute virus of canines. Nucleic Acids Res. 2025;53.","DOI":"10.1093\/nar\/gkaf229"},{"key":"1014_CR84","doi-asserted-by":"publisher","first-page":"6327","DOI":"10.1038\/s41467-023-42135-3","volume":"14","author":"Q Yan","year":"2023","unstructured":"Yan Q, Zhou J, Wang Z, Ding X, Ma X, Li W, Jia X, Gao SJ, Lu C. NAT10-dependent N(4)-acetylcytidine modification mediates PAN RNA stability, KSHV reactivation, and IFI16-related inflammasome activation. Nat Commun. 2023;14:6327.","journal-title":"Nat Commun"},{"key":"1014_CR85","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1016\/j.molcel.2022.06.022","volume":"82","author":"D Arango","year":"2022","unstructured":"Arango D, Sturgill D, Yang R, Kanai T, Bauer P, Roy J, Wang Z, Hosogane M, Schiffers S, Oberdoerffer S. Direct epitranscriptomic regulation of mammalian translation initiation through N4-acetylcytidine. Mol Cell. 2022;82:2912.","journal-title":"Mol Cell"},{"key":"1014_CR86","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41556-026-01949-1","volume":"28","author":"W Li","year":"2026","unstructured":"Li W, Huo Y, Zhang Z, Liu Y, Qian X, Ouyang J, Gu R, Han C, Li S, Su R, et al. NAT10 maintains stem cell homeostasis by mitigating mRNA decay through an ac(4)C-independent mechanism. Nat Cell Biol. 2026;28:1141\u201354.","journal-title":"Nat Cell Biol"},{"key":"1014_CR87","doi-asserted-by":"crossref","unstructured":"Park Y, He J, Suha E, Zhenyu W, Fiches GN, Zhou D, Watters EG, He ZM, Shanaka KA, Lepcha TT, et al. NAT10 suppresses RNA sensing induced IFN-\u03b2 transactivation to promote viral infection via interfering with IRF3 activities. bioRxiv. 2025.","DOI":"10.1101\/2025.09.01.673489"},{"key":"1014_CR88","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12964-024-01869-3","volume":"22","author":"K Su","year":"2024","unstructured":"Su K, Zhao Z, Wang Y, Sun S, Liu X, Zhang C, Jiang Y, Du X. NAT10 resolves harmful nucleolar R-loops depending on its helicase domain and acetylation of DDX21. Cell Commun Signal. 2024;22:490.","journal-title":"Cell Commun Signal"},{"key":"1014_CR89","doi-asserted-by":"crossref","unstructured":"Zhou M, Gamage ST, Tran KA, Bartee D, Wei X, Yin B, Berger S, Meier JL, Marmorstein R. Molecular basis for RNA cytidine acetylation by NAT10. bioRxiv. 2024.","DOI":"10.1101\/2024.03.27.587050"},{"key":"1014_CR90","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/cac2.12523","volume":"44","author":"D Miao","year":"2024","unstructured":"Miao D, Shi J, Lv Q, Tan D, Zhao C, Xiong Z, Zhang X. NAT10-mediated ac(4)C-modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear-cell renal cell carcinoma by attenuating YWHAE-driven cytoplasmic retention of YAP1. Cancer Commun (Lond). 2024;44:361\u201383.","journal-title":"Cancer Commun (Lond)"},{"key":"1014_CR91","doi-asserted-by":"publisher","first-page":"349","DOI":"10.33549\/physiolres.935656","volume":"75","author":"Y Tang","year":"2026","unstructured":"Tang Y, Wang Q, Dong W, Jiang G, Lei M, Hu X, Wu Y, Jiang W, Hao J, Hu Z. The Role of NAT10-Mediated ac4C Modification in Osteoblast Function and Bone Formation: Insights from Integrative Bioinformatics and Experimental Validation. Physiol Res. 2026;75:349\u201364.","journal-title":"Physiol Res"},{"key":"1014_CR92","doi-asserted-by":"publisher","first-page":"118703","DOI":"10.1016\/j.bios.2026.118703","volume":"305","author":"Z Yin","year":"2026","unstructured":"Yin Z, Liu H, Zhou Y, Yin H. Photoelectrochemical-colorimetric dual-mode biosensor for NAT10 protein detection based on in-situ formation of Bi(2)S(3)\/Bi(2)O(2)S Z-Scheme heterojunction catalyzed by reduced Ce-MOF. Biosens Bioelectron. 2026;305:118703.","journal-title":"Biosens Bioelectron"},{"key":"1014_CR93","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.yexcr.2009.03.007","volume":"315","author":"Q Shen","year":"2009","unstructured":"Shen Q, Zheng X, McNutt MA, Guang L, Sun Y, Wang J, Gong Y, Hou L, Zhang B. NAT10, a nucleolar protein, localizes to the midbody and regulates cytokinesis and acetylation of microtubules. Exp Cell Res. 2009;315:1653\u201367.","journal-title":"Exp Cell Res"},{"key":"1014_CR94","doi-asserted-by":"crossref","unstructured":"Zhang C, Lu J, Tang L, You H, Yin M, Gong Y, Wu J, Xiong C, Wu X, Li M, et al. The functions, mechanisms and clinical relevance of RNA and protein acetyltransferase NAT10: a comprehensive review. Cell Biol Toxicol. 2026.","DOI":"10.1007\/s10565-026-10227-7"},{"key":"1014_CR95","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.chembiol.2019.11.011","volume":"27","author":"MJ Levy","year":"2020","unstructured":"Levy MJ, Montgomery DC, Sardiu ME, Montano JL, Bergholtz SE, Nance KD, Thorpe AL, Fox SD, Lin Q, Andresson T, et al. A Systems Chemoproteomic Analysis of Acyl-CoA\/Protein Interaction Networks. Cell Chem Biol. 2020;27:322\u2013e333325.","journal-title":"Cell Chem Biol"},{"key":"1014_CR96","doi-asserted-by":"publisher","first-page":"108544","DOI":"10.1016\/j.jbc.2025.108544","volume":"301","author":"T Inoki","year":"2025","unstructured":"Inoki T, Tsuruta A, Masakado Y, Kai Y, Yoshida Y, Matsunaga N, Ohdo S, Koyanagi S. N-acetyltransferase 10 promotes glioblastoma malignancy via mRNA stabilization of jumonji and AT-rich interaction domain containing 2. J Biol Chem. 2025;301:108544.","journal-title":"J Biol Chem"},{"key":"1014_CR97","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1016\/j.molcel.2024.10.033","volume":"84","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, \u0106orovi\u0107 M, Hoch-Kraft P, Meiser N, Mesitov M, K\u00f6rtel N, Back H, Naarmann-de Vries IS, Katti K, Obrdl\u00edk A, et al. m6A sites in the coding region trigger translation-dependent mRNA decay. Mol Cell. 2024;84:4576\u2013e45934512.","journal-title":"Mol Cell"},{"key":"1014_CR98","doi-asserted-by":"publisher","first-page":"101728","DOI":"10.1016\/j.xcrm.2024.101728","volume":"5","author":"Y Zou","year":"2024","unstructured":"Zou Y, Guo S, Wen L, Lv D, Tu J, Liao Y, Chen W, Chen Z, Li H, Chen J, et al. Targeting NAT10 inhibits osteosarcoma progression via ATF4\/ASNS-mediated asparagine biosynthesis. Cell Rep Med. 2024;5:101728.","journal-title":"Cell Rep Med"},{"key":"1014_CR99","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s11658-024-00540-6","volume":"29","author":"C Zhang","year":"2024","unstructured":"Zhang C, Yuan L, Zou Q, Shao C, Jia Y, Li J, Liao Y, Zhao X, Wen W, Jing X, et al. CircMAST1 inhibits cervical cancer progression by hindering the N4-acetylcytidine modification of YAP mRNA. Cell Mol Biol Lett. 2024;29:25.","journal-title":"Cell Mol Biol Lett"},{"key":"1014_CR100","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/cac2.12595","volume":"44","author":"H Liu","year":"2024","unstructured":"Liu H, Xu L, Yue S, Su H, Chen X, Liu Q, Li H, Liang H, Chen X, He J, et al. Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation. Cancer Commun (Lond). 2024;44:1018\u201341.","journal-title":"Cancer Commun (Lond)"},{"key":"1014_CR101","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-019-0101-y","volume":"20","author":"MS Hipp","year":"2019","unstructured":"Hipp MS, Kasturi P, Hartl FU. The proteostasis network and its decline in ageing. Nat Rev Mol Cell Biol. 2019;20:421\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1014_CR102","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1146\/annurev-biophys-121219-081604","volume":"49","author":"L Ruan","year":"2020","unstructured":"Ruan L, Wang Y, Zhang X, Tomaszewski A, McNamara JT, Li R. Mitochondria-Associated Proteostasis. Annu Rev Biophys. 2020;49:41\u201367.","journal-title":"Annu Rev Biophys"},{"key":"1014_CR103","doi-asserted-by":"crossref","unstructured":"Zhong X, Mao J, Zhang J. Epitranscriptomic control of cancer: the emerging roles of m\u2075C and ac\u2074C RNA modifications. Cell Death Discov. 2026;12.","DOI":"10.1038\/s41420-026-03135-6"},{"key":"1014_CR104","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.semcdb.2023.06.003","volume":"154","author":"TJ Smith","year":"2024","unstructured":"Smith TJ, Giles RN, Koutmou KS. Anticodon stem-loop tRNA modifications influence codon decoding and frame maintenance during translation. Semin Cell Dev Biol. 2024;154:105\u201313.","journal-title":"Semin Cell Dev Biol"},{"key":"1014_CR105","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1261\/rna.067736.118","volume":"24","author":"L Han","year":"2018","unstructured":"Han L, Phizicky EM. A rationale for tRNA modification circuits in the anticodon loop. RNA. 2018;24:1277\u201384.","journal-title":"RNA"},{"key":"1014_CR106","doi-asserted-by":"publisher","first-page":"7087","DOI":"10.1007\/s00018-021-03948-x","volume":"78","author":"JB Zhou","year":"2021","unstructured":"Zhou JB, Wang ED, Zhou XL. Modifications of the human tRNA anticodon loop and their associations with genetic diseases. Cell Mol Life Sci. 2021;78:7087\u2013105.","journal-title":"Cell Mol Life Sci"},{"key":"1014_CR107","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1038\/emboj.2008.154","volume":"27","author":"Y Ikeuchi","year":"2008","unstructured":"Ikeuchi Y, Kitahara K, Suzuki T. The RNA acetyltransferase driven by ATP hydrolysis synthesizes N4-acetylcytidine of tRNA anticodon. Embo j. 2008;27:2194\u2013203.","journal-title":"Embo j"},{"key":"1014_CR108","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/s41589-018-0119-z","volume":"14","author":"T Taniguchi","year":"2018","unstructured":"Taniguchi T, Miyauchi K, Sakaguchi Y, Yamashita S, Soma A, Tomita K, Suzuki T. Acetate-dependent tRNA acetylation required for decoding fidelity in protein synthesis. Nat Chem Biol. 2018;14:1010\u201320.","journal-title":"Nat Chem Biol"},{"key":"1014_CR109","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.molmed.2022.09.007","volume":"28","author":"PC Dedon","year":"2022","unstructured":"Dedon PC, Begley TJ. Dysfunctional tRNA reprogramming and codon-biased translation in cancer. Trends Mol Med. 2022;28:964\u201378.","journal-title":"Trends Mol Med"},{"key":"1014_CR110","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrm.2017.91","volume":"19","author":"G Hanson","year":"2018","unstructured":"Hanson G, Coller J. Codon optimality, bias and usage in translation and mRNA decay. Nat Rev Mol Cell Biol. 2018;19:20\u201330.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1014_CR111","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/15476286.2015.1031947","volume":"12","author":"L Endres","year":"2015","unstructured":"Endres L, Dedon PC, Begley TJ. Codon-biased translation can be regulated by wobble-base tRNA modification systems during cellular stress responses. RNA Biol. 2015;12:603\u201314.","journal-title":"RNA Biol"},{"key":"1014_CR112","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12964-023-01417-5","volume":"22","author":"S Zhang","year":"2024","unstructured":"Zhang S, Liu Y, Ma X, Gao X, Ru Y, Hu X, Gu X. Recent advances in the potential role of RNA N4-acetylcytidine in cancer progression. Cell Commun Signal. 2024;22:49.","journal-title":"Cell Commun Signal"},{"key":"1014_CR113","doi-asserted-by":"publisher","first-page":"26201","DOI":"10.1074\/jbc.M114.593996","volume":"289","author":"S Ito","year":"2014","unstructured":"Ito S, Akamatsu Y, Noma A, Kimura S, Miyauchi K, Ikeuchi Y, Suzuki T, Suzuki T. A single acetylation of 18S rRNA is essential for biogenesis of the small ribosomal subunit in Saccharomyces cerevisiae. J Biol Chem. 2014;289:26201\u201312.","journal-title":"J Biol Chem"},{"key":"1014_CR114","doi-asserted-by":"publisher","first-page":"35724","DOI":"10.1074\/jbc.C114.602698","volume":"289","author":"S Ito","year":"2014","unstructured":"Ito S, Horikawa S, Suzuki T, Kawauchi H, Tanaka Y, Suzuki T, Suzuki T. Human NAT10 is an ATP-dependent RNA acetyltransferase responsible for N4-acetylcytidine formation in 18S ribosomal RNA (rRNA). J Biol Chem. 2014;289:35724\u201330.","journal-title":"J Biol Chem"},{"key":"1014_CR115","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.1093\/nar\/gkac404","volume":"50","author":"ML Bortolin-Cavaill\u00e9","year":"2022","unstructured":"Bortolin-Cavaill\u00e9 ML, Quillien A, Thalalla Gamage S, Thomas JM, Sas-Chen A, Sharma S, Plisson-Chastang C, Vandel L, Blader P, Lafontaine DLJ, et al. Probing small ribosomal subunit RNA helix 45 acetylation across eukaryotic evolution. Nucleic Acids Res. 2022;50:6284\u201399.","journal-title":"Nucleic Acids Res"},{"key":"1014_CR116","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.nbt.2026.01.003","volume":"92","author":"N Qin","year":"2026","unstructured":"Qin N, Wang Y, Yuan Q, Chen L, Qu GS. Locus-specific quantification reveals dynamics of ribosomal ac4C modifications. N Biotechnol. 2026;92:62\u201373.","journal-title":"N Biotechnol"},{"key":"1014_CR117","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/procel\/pwaf013","volume":"16","author":"Z Wubulikasimu","year":"2025","unstructured":"Wubulikasimu Z, Zhao H, Mao F, Zhao X. Emerging roles of RNA N4-acetylcytidine modification in reproductive health. Protein Cell. 2025;16:458\u201377.","journal-title":"Protein Cell"},{"key":"1014_CR118","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00441-021-03530-8","volume":"386","author":"E Yildirim","year":"2021","unstructured":"Yildirim E, Bora G, Onel T, Talas N, Yaba A. Cell fate determination and Hippo signaling pathway in preimplantation mouse embryo. Cell Tissue Res. 2021;386:423\u201344.","journal-title":"Cell Tissue Res"},{"key":"1014_CR119","doi-asserted-by":"crossref","unstructured":"Lee YJ. Cell fate determination of lymphatic endothelial cells. Int J Mol Sci. 2020;21.","DOI":"10.3390\/ijms21134790"},{"key":"1014_CR120","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/nph.20230","volume":"245","author":"X Huang","year":"2025","unstructured":"Huang X, Sun MX. Cell fate determination during sexual plant reproduction. New Phytol. 2025;245:480\u201395.","journal-title":"New Phytol"},{"key":"1014_CR121","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1038\/s41375-025-02765-6","volume":"39","author":"M Eleftheriou","year":"2025","unstructured":"Eleftheriou M, Russell J, Tzelepis K. Epitranscriptomic advances in normal and malignant hematopoiesis. Leukemia. 2025;39:2848\u201357.","journal-title":"Leukemia"},{"key":"1014_CR122","doi-asserted-by":"crossref","unstructured":"Feng G, Yin G, Liu Y, Liu C, Li J, Lu J, Yu Y, Jin Z, Wu Y, Yue Y, et al. Nat10 maintains the homeostasis of pluripotent and 2-cell-like states in mouse embryonic stem cells through mRNA cytidine acetylation. Nucleic Acids Res. 2025;53.","DOI":"10.1093\/nar\/gkaf504"},{"key":"1014_CR123","doi-asserted-by":"publisher","first-page":"8514","DOI":"10.1093\/nar\/gkad628","volume":"51","author":"R Liu","year":"2023","unstructured":"Liu R, Wubulikasimu Z, Cai R, Meng F, Cui Q, Zhou Y, Li Y. NAT10-mediated N4-acetylcytidine mRNA modification regulates self-renewal in human embryonic stem cells. Nucleic Acids Res. 2023;51:8514\u201331.","journal-title":"Nucleic Acids Res"},{"key":"1014_CR124","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00018-023-04955-w","volume":"80","author":"M Wang","year":"2023","unstructured":"Wang M, Cheng R, He H, Han Z, Zhang Y, Wu Q. N(4)-acetylcytidine of Nop2 mRNA is required for the transition of morula-to-blastocyst. Cell Mol Life Sci. 2023;80:307.","journal-title":"Cell Mol Life Sci"},{"key":"1014_CR125","doi-asserted-by":"publisher","first-page":"eadh9871","DOI":"10.1126\/sciadv.adh9871","volume":"10","author":"Z Hu","year":"2024","unstructured":"Hu Z, Lu Y, Cao J, Lin L, Chen X, Zhou Z, Pu J, Chen G, Ma X, Deng Q, et al. N-acetyltransferase NAT10 controls cell fates via connecting mRNA cytidine acetylation to chromatin signaling. Sci Adv. 2024;10:eadh9871.","journal-title":"Sci Adv"},{"key":"1014_CR126","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.1074\/jbc.271.10.5941","volume":"271","author":"HK Simmerman","year":"1996","unstructured":"Simmerman HK, Kobayashi YM, Autry JM, Jones LR. A leucine zipper stabilizes the pentameric membrane domain of phospholamban and forms a coiled-coil pore structure. J Biol Chem. 1996;271:5941\u20136.","journal-title":"J Biol Chem"},{"key":"1014_CR127","doi-asserted-by":"publisher","first-page":"8833527","DOI":"10.1155\/2021\/8833527","volume":"2021","author":"Z Zhu","year":"2021","unstructured":"Zhu Z, Xing X, Huang S, Tu Y. NAT10 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells by Mediating N4-Acetylcytidine Modification of Gremlin 1. Stem Cells Int. 2021;2021:8833527.","journal-title":"Stem Cells Int"},{"key":"1014_CR128","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1007\/s10266-023-00793-1","volume":"111","author":"Z Cui","year":"2023","unstructured":"Cui Z, Xu Y, Wu P, Lu Y, Tao Y, Zhou C, Cui R, Li J, Han R. NAT10 promotes osteogenic differentiation of periodontal ligament stem cells by regulating VEGFA-mediated PI3K\/AKT signaling pathway through ac4C modification. Odontology. 2023;111:870\u201382.","journal-title":"Odontology"},{"key":"1014_CR129","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jare.2024.07.031","volume":"72","author":"R Yang","year":"2025","unstructured":"Yang R, Yu W, Lin L, Cui Z, Tang J, Li G, Jin M, Gu Y, Lu E. NAT10 promotes osteoclastogenesis in inflammatory bone loss by catalyzing Fos mRNA ac4C modification and upregulating MAPK signaling pathway. J Adv Res. 2025;72:303\u201317.","journal-title":"J Adv Res"},{"key":"1014_CR130","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1038\/s41467-023-39256-0","volume":"14","author":"X Jiang","year":"2023","unstructured":"Jiang X, Cheng Y, Zhu Y, Xu C, Li Q, Xing X, Li W, Zou J, Meng L, Azhar M, et al. Maternal NAT10 orchestrates oocyte meiotic cell-cycle progression and maturation in mice. Nat Commun. 2023;14:3729.","journal-title":"Nat Commun"},{"key":"1014_CR131","doi-asserted-by":"publisher","first-page":"907286","DOI":"10.3389\/fendo.2022.907286","volume":"13","author":"J Lin","year":"2022","unstructured":"Lin J, Xiang Y, Huang J, Zeng H, Zeng Y, Liu J, Wu T, Liang Q, Liang X, Li J, Zhou C. NAT10 Maintains OGA mRNA Stability Through ac4C Modification in Regulating Oocyte Maturation. Front Endocrinol (Lausanne). 2022;13:907286.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1014_CR132","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.scib.2024.09.020","volume":"70","author":"WJ Wang","year":"2025","unstructured":"Wang WJ, Wu YK, Liu SY, Chen L, Wu HB, Fan HY. NAT10-mediated mRNA N4-acetylcytidine modifications in mouse oocytes constitute a checkpoint of ovarian follicle development. Sci Bull (Beijing). 2025;70:837\u201341.","journal-title":"Sci Bull (Beijing)"},{"key":"1014_CR133","doi-asserted-by":"publisher","first-page":"e70444","DOI":"10.1096\/fj.202402751R","volume":"39","author":"Z Cui","year":"2025","unstructured":"Cui Z, Fu C, Ai D, Zhu H, Wang F, An X, Li Z, Zhang S. NAT10 regulates zygotic genome activation and the morula-to-blastocyst transition. Faseb j. 2025;39:e70444.","journal-title":"Faseb j"},{"key":"1014_CR134","doi-asserted-by":"publisher","first-page":"eadu0955","DOI":"10.1126\/sciadv.adu0955","volume":"11","author":"Y Xie","year":"2025","unstructured":"Xie Y, Zhou C, Guo Q, Guo Y, Guo J, Chen L, Liu X, Zeng Y, Liang Q, Wu T, et al. Nicotinamide boosts oocyte quantity and quality by promoting N4-acetylation modification in lupus mice. Sci Adv. 2025;11:eadu0955.","journal-title":"Sci Adv"},{"key":"1014_CR135","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jgg.2024.06.020","volume":"51","author":"DL Shi","year":"2024","unstructured":"Shi DL. Interplay of RNA-binding proteins controls germ cell development in zebrafish. J Genet Genomics. 2024;51:889\u201399.","journal-title":"J Genet Genomics"},{"key":"1014_CR136","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/cge.12882","volume":"91","author":"R Hersmus","year":"2017","unstructured":"Hersmus R, van Bever Y, Wolffenbuttel KP, Biermann K, Cools M, Looijenga LH. The biology of germ cell tumors in disorders of sex development. Clin Genet. 2017;91:292\u2013301.","journal-title":"Clin Genet"},{"key":"1014_CR137","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.cell.2008.10.048","volume":"135","author":"A Wilson","year":"2008","unstructured":"Wilson A, Laurenti E, Oser G, van der Wath RC, Blanco-Bose W, Jaworski M, Offner S, Dunant CF, Eshkind L, Bockamp E, et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell. 2008;135:1118\u201329.","journal-title":"Cell"},{"key":"1014_CR138","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.stem.2024.07.009","volume":"31","author":"C Du","year":"2024","unstructured":"Du C, Liu C, Yu K, Zhang S, Fu Z, Chen X, Liao W, Chen J, Zhang Y, Wang X, et al. Mitochondrial serine catabolism safeguards maintenance of the hematopoietic stem cell pool in homeostasis and injury. Cell Stem Cell. 2024;31:1484\u2013e15001489.","journal-title":"Cell Stem Cell"},{"key":"1014_CR139","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s44161-024-00482-4","volume":"3","author":"RS Carpenter","year":"2024","unstructured":"Carpenter RS, Maryanovich M. Systemic and local regulation of hematopoietic homeostasis in health and disease. Nat Cardiovasc Res. 2024;3:651\u201365.","journal-title":"Nat Cardiovasc Res"},{"key":"1014_CR140","doi-asserted-by":"publisher","first-page":"e2300898","DOI":"10.1002\/advs.202300898","volume":"10","author":"Q Yang","year":"2023","unstructured":"Yang Q, Lei X, He J, Peng Y, Zhang Y, Ling R, Wu C, Zhang G, Zheng B, Chen X, et al. N4-Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10\/SEPT9\/HIF-1\u03b1 Positive Feedback Loop. Adv Sci (Weinh). 2023;10:e2300898.","journal-title":"Adv Sci (Weinh)"},{"key":"1014_CR141","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s40164-025-00721-9","volume":"14","author":"S Fang","year":"2025","unstructured":"Fang S, Zhu Y, Chen W, Mao W, Fang Y, Chen Z, Hong Z, Zhao X, Su W, Pan Y, et al. NAT10-mediated lipid metabolic reprogramming drives EGFR-TKI resistance in non-small cell lung cancer via ac4C-dependent mRNA stabilization. Exp Hematol Oncol. 2025;14:134.","journal-title":"Exp Hematol Oncol"},{"key":"1014_CR142","doi-asserted-by":"publisher","first-page":"108236","DOI":"10.1016\/j.micpath.2025.108236","volume":"211","author":"J Wu","year":"2026","unstructured":"Wu J, Shi M, Zhu L, Zheng X, Liao C, Peng RR, Long FQ. MiR-330-3p promotes T cell ferroptosis and IFN-\u03b3 production via targeting NAT10 in neurosyphilis. Microb Pathog. 2026;211:108236.","journal-title":"Microb Pathog"},{"key":"1014_CR143","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.2147\/CMAR.S197733","volume":"11","author":"Z Liu","year":"2019","unstructured":"Liu Z, Liu X, Li Y, Ren P, Zhang C, Wang L, Du X, Xing B. miR-6716-5p promotes metastasis of colorectal cancer through downregulating NAT10 expression. Cancer Manag Res. 2019;11:5317\u201332.","journal-title":"Cancer Manag Res"},{"key":"1014_CR144","doi-asserted-by":"publisher","first-page":"150934","DOI":"10.1016\/j.ijbiomac.2026.150934","volume":"350","author":"SH Xie","year":"2026","unstructured":"Xie SH, Xu SD, Mo AT, Tang Y, Wu JH, Zhuang WT, Duan JL, Huang CJ, Li SW, Qiao GB, et al. CircTHBS1 stabilizes N-acetyltransferase 10 to promote N(4)-acetylcytidine-dependent Rab8a translation and autophagy in esophageal squamous cell carcinoma. Int J Biol Macromol. 2026;350:150934.","journal-title":"Int J Biol Macromol"},{"key":"1014_CR145","doi-asserted-by":"publisher","first-page":"e02931","DOI":"10.1002\/advs.202502931","volume":"12","author":"YJ Zhan","year":"2025","unstructured":"Zhan YJ, Deng CM, Tang L, Li SJ, Xu TY, Wei X, Zhang XY, Zheng CC, Deng L, Shao C, et al. NAT10 Increases Lysosomal Acidification to Promote Esophageal Cancer Metastasis via ac4C Acetylation of ATP6V0E1 mRNA. Adv Sci (Weinh). 2025;12:e02931.","journal-title":"Adv Sci (Weinh)"},{"key":"1014_CR146","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13046-025-03277-y","volume":"44","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Song D, Guo M, Wang C, Ma M, Tao G, Liu L, He X, Cao F, Luo D, et al. EGFR inhibition augments the therapeutic efficacy of the NAT10 inhibitor Remodelin in Colorectal cancer. J Exp Clin Cancer Res. 2025;44:37.","journal-title":"J Exp Clin Cancer Res"},{"key":"1014_CR147","doi-asserted-by":"publisher","first-page":"e2501185123","DOI":"10.1073\/pnas.2501185123","volume":"123","author":"WD Yang","year":"2026","unstructured":"Yang WD, Lu MR, Shen Q, Zhou PH, Diao Y, Xia S, Lu YC, Cui YQ, Li BQ, Xu WX, et al. Lactylated NAT10 contributes to elesclomol-triggered cuproptosis via the NAT10\/ac4C-DLAT-mRNA\/DLAT positive feedback loop in CRC. Proc Natl Acad Sci U S A. 2026;123:e2501185123.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1014_CR148","doi-asserted-by":"publisher","first-page":"e154","DOI":"10.1002\/cai2.154","volume":"4","author":"Y Han","year":"2025","unstructured":"Han Y, Zhang X, Miao L, Lin H, Zhuo Z, He J, Fu W. Biological function and mechanism of NAT10 in cancer. Cancer Innov. 2025;4:e154.","journal-title":"Cancer Innov"},{"key":"1014_CR149","doi-asserted-by":"publisher","first-page":"e2310131","DOI":"10.1002\/advs.202310131","volume":"11","author":"KJ Li","year":"2024","unstructured":"Li KJ, Hong Y, Yu YZ, Xie Z, Lv DJ, Wang C, Xie T, Chen H, Chen ZS, Zeng J, Zhao SC. NAT10 Promotes Prostate Cancer Growth and Metastasis by Acetylating mRNAs of HMGA1 and KRT8. Adv Sci (Weinh). 2024;11:e2310131.","journal-title":"Adv Sci (Weinh)"},{"key":"1014_CR150","doi-asserted-by":"publisher","first-page":"e738","DOI":"10.1002\/ctm2.738","volume":"12","author":"G Wang","year":"2022","unstructured":"Wang G, Zhang M, Zhang Y, Xie Y, Zou J, Zhong J, Zheng Z, Zhou X, Zheng Y, Chen B, Liu C. NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression. Clin Transl Med. 2022;12:e738.","journal-title":"Clin Transl Med"},{"key":"1014_CR151","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41419-025-08328-y","volume":"17","author":"X Meng","year":"2025","unstructured":"Meng X, Dong T, Xu J, Tian K, Yang W, Liu Z, Qian Y, Liu D, Chen C, Bai J, et al. NAT10-mediated N4-acetylcytidine (ac4C) modification of PIK3R2 mRNA promotes malignant progression of glioblastoma. Cell Death Dis. 2025;17:106.","journal-title":"Cell Death Dis"},{"key":"1014_CR152","doi-asserted-by":"crossref","unstructured":"Song P, Xiao Q, Jiang Y, Li H, Liang Z, Wang J, Qian X, Gao X. NAT10 drives head and neck squamous cell carcinoma proliferation via ac4C modification of DDIT4 mRNA. Sci Rep. 2026.","DOI":"10.1038\/s41598-026-60979-9"},{"key":"1014_CR153","doi-asserted-by":"publisher","first-page":"e70597","DOI":"10.1002\/jbt.70597","volume":"39","author":"A Zhu","year":"2025","unstructured":"Zhu A, Zhou C, Dong J, Huang C, Zhu M, Gu J, Xu J. FOXA1-NAT10 Positive Feedback Pathway Promotes Non-Small Cell Lung Cancer Cell Progression. J Biochem Mol Toxicol. 2025;39:e70597.","journal-title":"J Biochem Mol Toxicol"},{"key":"1014_CR154","doi-asserted-by":"publisher","first-page":"38928","DOI":"10.1038\/s41598-025-22902-6","volume":"15","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Shen Y. NAT10 promotes glycolysis and cell stemness of ovarian cancer cells via ac4C acetylation of PGAM1 mRNA. Sci Rep. 2025;15:38928.","journal-title":"Sci Rep"},{"key":"1014_CR155","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1038\/s41556-024-01548-y","volume":"26","author":"S Zhang","year":"2024","unstructured":"Zhang S, Huang F, Wang Y, Long Y, Li Y, Kang Y, Gao W, Zhang X, Wen Y, Wang Y, et al. NAT10-mediated mRNA N(4)-acetylcytidine reprograms serine metabolism to drive leukaemogenesis and stemness in acute myeloid leukaemia. Nat Cell Biol. 2024;26:2168\u201382.","journal-title":"Nat Cell Biol"},{"key":"1014_CR156","doi-asserted-by":"publisher","first-page":"e30330","DOI":"10.1016\/j.heliyon.2024.e30330","volume":"10","author":"LP Gao","year":"2024","unstructured":"Gao LP, Li TD, Yang SZ, Ma HM, Wang X, Zhang DK. NAT10-mediated ac(4)C modification promotes stemness and chemoresistance of colon cancer by stabilizing NANOGP8. Heliyon. 2024;10:e30330.","journal-title":"Heliyon"},{"key":"1014_CR157","doi-asserted-by":"publisher","first-page":"112860","DOI":"10.1016\/j.isci.2025.112860","volume":"28","author":"H Li","year":"2025","unstructured":"Li H, Wu H, Li S, Wang Q, Li G, Ma X, Gong Y, Chu Y, Jin S, Chen X, et al. Mechanistic study of N-acetyltransferase 10 deficiency enhancing olaparib sensitivity in triple negative breast cancer by inhibiting RAD51 N4-acetylcytidine modification. iScience. 2025;28:112860.","journal-title":"iScience"},{"key":"1014_CR158","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1158\/0008-5472.CAN-22-2233","volume":"83","author":"R Xie","year":"2023","unstructured":"Xie R, Cheng L, Huang M, Huang L, Chen Z, Zhang Q, Li H, Lu J, Wang H, Zhou Q, et al. NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer. Cancer Res. 2023;83:1666\u201383.","journal-title":"Cancer Res"},{"key":"1014_CR159","doi-asserted-by":"publisher","first-page":"e7283","DOI":"10.1002\/cam4.7283","volume":"13","author":"Q Guo","year":"2024","unstructured":"Guo Q, Yu W, Tan J, Zhang J, Chen J, Rao S, Guo X, Cai K. Remodelin delays non-small cell lung cancer progression by inhibiting NAT10 via the EMT pathway. Cancer Med. 2024;13:e7283.","journal-title":"Cancer Med"},{"key":"1014_CR160","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1007\/s10620-024-08472-z","volume":"69","author":"S Song","year":"2024","unstructured":"Song S, Li B, Jin X, Li H, Wang H, Wang F, He Y, Zhang C. NAT10 Overexpression Promotes Tumorigenesis and Epithelial-Mesenchymal Transition Through AKT Pathway in Gastric Cancer. Dig Dis Sci. 2024;69:3261\u201375.","journal-title":"Dig Dis Sci"},{"key":"1014_CR161","doi-asserted-by":"publisher","first-page":"112447","DOI":"10.1016\/j.mce.2024.112447","volume":"597","author":"N Liu","year":"2025","unstructured":"Liu N, YangOu J, Wei C, Li G, Yu R, Lin Y, Xu H. NAT10 drives endometriosis progression through acetylation and stabilization of TGFB1 mRNA. Mol Cell Endocrinol. 2025;597:112447.","journal-title":"Mol Cell Endocrinol"},{"key":"1014_CR162","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12905-025-03567-9","volume":"25","author":"Y Song","year":"2025","unstructured":"Song Y, Cheng M. NAT10 promotes ovarian cancer cell migration, invasion, and stemness via N4-acetylcytidine modification of CAPRIN1. BMC Womens Health. 2025;25:54.","journal-title":"BMC Womens Health"},{"key":"1014_CR163","doi-asserted-by":"publisher","first-page":"eads6021","DOI":"10.1126\/sciadv.ads6021","volume":"11","author":"JF Chen","year":"2025","unstructured":"Chen JF, Xu P, Cai WL, Chen H, Wingrove E, Shi X, Li W, Biancon G, Zhang M, Balabaki A, et al. An in vivo screen identifies NAT10 as a master regulator of brain metastasis. Sci Adv. 2025;11:eads6021.","journal-title":"Sci Adv"},{"key":"1014_CR164","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.7150\/thno.104310","volume":"15","author":"Q Wang","year":"2025","unstructured":"Wang Q, Li M, Chen C, Xu L, Fu Y, Xu J, Shu C, Wang B, Wang Z, Chen C, et al. Glucose homeostasis controls N-acetyltransferase 10-mediated ac4C modification of HK2 to drive gastric tumorigenesis. Theranostics. 2025;15:2428\u201350.","journal-title":"Theranostics"},{"key":"1014_CR165","doi-asserted-by":"publisher","first-page":"116688","DOI":"10.1016\/j.taap.2023.116688","volume":"477","author":"Z Yang","year":"2023","unstructured":"Yang Z, Wilkinson E, Cui YH, Li H, He YY. NAT10 regulates the repair of UVB-induced DNA damage and tumorigenicity. Toxicol Appl Pharmacol. 2023;477:116688.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1014_CR166","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12890-024-03463-2","volume":"25","author":"Y Yuan","year":"2025","unstructured":"Yuan Y, Li N, Zhu J, Shao C, Zeng X, Yi D. Role of NAT10-mediated ac(4)C acetylation of ENO1 mRNA in glycolysis and apoptosis in non-small cell lung cancer cells. BMC Pulm Med. 2025;25:75.","journal-title":"BMC Pulm Med"},{"key":"1014_CR167","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12885-026-15546-w","volume":"26","author":"Z Li","year":"2026","unstructured":"Li Z, Xie W, Wang L, Wu G. NAT10 promotes the glycolysis of retinoblastoma through ac4C modification of PFKFB3 mRNA. BMC Cancer. 2026;26:221.","journal-title":"BMC Cancer"},{"key":"1014_CR168","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13046-024-03200-x","volume":"43","author":"G Li","year":"2024","unstructured":"Li G, Ma X, Sui S, Chen Y, Li H, Liu L, Zhang X, Zhang L, Hao Y, Yang Z, et al. NAT10\/ac4C\/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction. J Exp Clin Cancer Res. 2024;43:278.","journal-title":"J Exp Clin Cancer Res"},{"key":"1014_CR169","doi-asserted-by":"publisher","first-page":"e2302705","DOI":"10.1002\/advs.202302705","volume":"10","author":"X Chen","year":"2023","unstructured":"Chen X, Hao Y, Liu Y, Zhong S, You Y, Ao K, Chong T, Luo X, Yin M, Ye M, et al. NAT10\/ac4C\/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer. Adv Sci (Weinh). 2023;10:e2302705.","journal-title":"Adv Sci (Weinh)"},{"key":"1014_CR170","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.molimm.2026.04.010","volume":"194","author":"D Yang","year":"2026","unstructured":"Yang D, Zhu Y, Liu Y, Dai Z. NAT10 promotes lung cancer progression by enhancing glutamine metabolism through increasing ac4C modification on NIT2. Mol Immunol. 2026;194:104\u201313.","journal-title":"Mol Immunol"},{"key":"1014_CR171","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s10616-026-01010-x","volume":"78","author":"L Xu","year":"2026","unstructured":"Xu L, Huang Z. SP1-mediated NAT10 upregulation drives oral squamous cell carcinoma progression via ac4C-dependent SLC1A5 modification. Cytotechnology. 2026;78:140.","journal-title":"Cytotechnology"},{"key":"1014_CR172","doi-asserted-by":"publisher","first-page":"e1045","DOI":"10.1002\/ctm2.1045","volume":"12","author":"MH Dalhat","year":"2022","unstructured":"Dalhat MH, Mohammed MRS, Alkhatabi HA, Rehan M, Ahmad A, Choudhry H, Khan MI. NAT10: An RNA cytidine transferase regulates fatty acid metabolism in cancer cells. Clin Transl Med. 2022;12:e1045.","journal-title":"Clin Transl Med"},{"key":"1014_CR173","doi-asserted-by":"publisher","first-page":"101934","DOI":"10.1016\/j.tranon.2024.101934","volume":"45","author":"C Jin","year":"2024","unstructured":"Jin C, Gao J, Zhu J, Ao Y, Shi B, Li X. Exosomal NAT10 from esophageal squamous cell carcinoma cells modulates macrophage lipid metabolism and polarization through ac4C modification of FASN. Transl Oncol. 2024;45:101934.","journal-title":"Transl Oncol"},{"key":"1014_CR174","doi-asserted-by":"publisher","first-page":"111972","DOI":"10.1016\/j.cbi.2026.111972","volume":"429","author":"W Gu","year":"2026","unstructured":"Gu W, Ren Z, Gao J, Shen Z, Wang Y, Xu L, Qian R, Miao Q, Wu Y, Hu X, et al. Inhibiting NAT10 suppresses hepatocellular carcinoma progression by reducing Nrf2 mRNA stability and increasing oxidative stress. Chem Biol Interact. 2026;429:111972.","journal-title":"Chem Biol Interact"},{"key":"1014_CR175","doi-asserted-by":"publisher","first-page":"e70496","DOI":"10.1002\/jbt.70496","volume":"39","author":"C Wang","year":"2025","unstructured":"Wang C, Liu J, Chang H, Wu Y, Chai Z, Jia P, Yuan Y, Tan L. NAT10-Mediated N4-Acetylation of SLC7A11 mRNA Promotes Hepatocellular Carcinoma Progression and Metastasis by Repressing Ferroptosis. J Biochem Mol Toxicol. 2025;39:e70496.","journal-title":"J Biochem Mol Toxicol"},{"key":"1014_CR176","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1111\/cas.16249","volume":"115","author":"Z Xue","year":"2024","unstructured":"Xue Z, Xie H, Shan Y, Zhang L, Cheng L, Chen W, Zhu R, Zhang K, Ni H, Zhang Z, et al. NAT10 inhibition promotes ac4C-dependent ferroptosis to counteract sorafenib resistance in nasopharyngeal carcinoma. Cancer Sci. 2024;115:3256\u201372.","journal-title":"Cancer Sci"},{"key":"1014_CR177","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/cac2.12363","volume":"42","author":"X Zheng","year":"2022","unstructured":"Zheng X, Wang Q, Zhou Y, Zhang D, Geng Y, Hu W, Wu C, Shi Y, Jiang J. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. Cancer Commun (Lond). 2022;42:1347\u201366.","journal-title":"Cancer Commun (Lond)"},{"key":"1014_CR178","doi-asserted-by":"publisher","first-page":"e20224","DOI":"10.7717\/peerj.20224","volume":"13","author":"C Tan","year":"2025","unstructured":"Tan C, Wang Y, Zhang X, Li Z, Chen S. NAT10 inhibits ferroptosis and promotes the progression of renal clear cell carcinoma by regulating the NFE2L1-GPX4 signaling pathway. PeerJ. 2025;13:e20224.","journal-title":"PeerJ"},{"key":"1014_CR179","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1186\/s12885-025-14352-0","volume":"25","author":"Y Yu","year":"2025","unstructured":"Yu Y, Yan J. NAT10 inhibits the pyroptosis of laryngeal squamous cell carcinoma through ac4C modification of ELANE mRNA. BMC Cancer. 2025;25:970.","journal-title":"BMC Cancer"},{"key":"1014_CR180","doi-asserted-by":"publisher","first-page":"139823","DOI":"10.1016\/j.ijbiomac.2025.139823","volume":"297","author":"N Xiao","year":"2025","unstructured":"Xiao N, Liu H, Zhang R, Li Y, Zhao X, Chen H, Zhang C, Zhu Y, Lu H, Wang X, et al. N-acetyltransferase 10 impedes EZH2\/H3K27me3\/GABARAP axis mediated autophagy and facilitates lung cancer tumorigenesis through enhancing SGK2 mRNA acetylation. Int J Biol Macromol. 2025;297:139823.","journal-title":"Int J Biol Macromol"},{"key":"1014_CR181","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0940-2993(96)80039-X","volume":"48","author":"MJ Iatropoulos","year":"1996","unstructured":"Iatropoulos MJ, Williams GM. Proliferation markers. Exp Toxicol Pathol. 1996;48:175\u201381.","journal-title":"Exp Toxicol Pathol"},{"key":"1014_CR182","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, Yi P, Tang L, Pan Q, Rao S, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20:28.","journal-title":"Mol Cancer"},{"key":"1014_CR183","doi-asserted-by":"publisher","first-page":"1695495","DOI":"10.3389\/fimmu.2025.1695495","volume":"16","author":"C Li","year":"2025","unstructured":"Li C, Jiang X, Jia Y, Zhou Q, Yuan Y, Wang Q. The critical role of NAT10-mediated N4-acetylcytidine modification in tumor immunity. Front Immunol. 2025;16:1695495.","journal-title":"Front Immunol"},{"key":"1014_CR184","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41419-023-06373-z","volume":"15","author":"Y Shuai","year":"2024","unstructured":"Shuai Y, Zhang H, Liu C, Wang J, Jiang Y, Sun J, Gao X, Bo X, Xiao X, Liao X, et al. CLIC3 interacts with NAT10 to inhibit N4-acetylcytidine modification of p21 mRNA and promote bladder cancer progression. Cell Death Dis. 2024;15:9.","journal-title":"Cell Death Dis"},{"key":"1014_CR185","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.stem.2024.06.003","volume":"31","author":"PE Saw","year":"2024","unstructured":"Saw PE, Liu Q, Wong PP, Song E. Cancer stem cell mimicry for immune evasion and therapeutic resistance. Cell Stem Cell. 2024;31:1101\u201312.","journal-title":"Cell Stem Cell"},{"key":"1014_CR186","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12015-018-9808-y","volume":"14","author":"MMJ Mens","year":"2018","unstructured":"Mens MMJ, Ghanbari M. Cell Cycle Regulation of Stem Cells by MicroRNAs. Stem Cell Rev Rep. 2018;14:309\u201322.","journal-title":"Stem Cell Rev Rep"},{"key":"1014_CR187","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4161\/15384101.2014.974419","volume":"14","author":"YA Shen","year":"2015","unstructured":"Shen YA, Wang CY, Hsieh YT, Chen YJ, Wei YH. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma. Cell Cycle. 2015;14:86\u201398.","journal-title":"Cell Cycle"},{"key":"1014_CR188","doi-asserted-by":"crossref","unstructured":"Mamouni K, Kim J, Lokeshwar BL, Kallifatidis G. ARRB1 regulates metabolic reprogramming to promote glycolysis in stem cell-like bladder cancer cells. Cancers (Basel). 2021;13.","DOI":"10.3390\/cancers13081809"},{"key":"1014_CR189","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.dnarep.2019.03.007","volume":"77","author":"C Ribeiro-Silva","year":"2019","unstructured":"Ribeiro-Silva C, Vermeulen W, Lans H. SWI\/SNF: Complex complexes in genome stability and cancer. DNA Repair (Amst). 2019;77:87\u201395.","journal-title":"DNA Repair (Amst)"},{"key":"1014_CR190","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41580-022-00452-3","volume":"23","author":"Y Pommier","year":"2022","unstructured":"Pommier Y, Nussenzweig A, Takeda S, Austin C. Human topoisomerases and their roles in genome stability and organization. Nat Rev Mol Cell Biol. 2022;23:407\u201327.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1014_CR191","doi-asserted-by":"crossref","unstructured":"Yag\u00fce-Capilla M, Rudd SG. Understanding the interplay between dNTP metabolism and genome stability in cancer. Dis Model Mech. 2024;17.","DOI":"10.1242\/dmm.050775"},{"key":"1014_CR192","doi-asserted-by":"publisher","first-page":"101241","DOI":"10.1016\/j.drup.2025.101241","volume":"81","author":"Z Xu","year":"2025","unstructured":"Xu Z, Zhu M, Geng L, Zhang J, Xia J, Wang Q, An H, Xia A, Yu Y, Liu S, et al. Targeting NAT10 attenuates homologous recombination via destabilizing DNA:RNA hybrids and overcomes PARP inhibitor resistance in cancers. Drug Resist Updat. 2025;81:101241.","journal-title":"Drug Resist Updat"},{"key":"1014_CR193","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147:275\u201392.","journal-title":"Cell"},{"key":"1014_CR194","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","volume":"30","author":"B Bakir","year":"2020","unstructured":"Bakir B, Chiarella AM, Pitarresi JR, Rustgi AK. EMT, MET, Plasticity, and Tumor Metastasis. Trends Cell Biol. 2020;30:764\u201376.","journal-title":"Trends Cell Biol"},{"key":"1014_CR195","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-3-319-96445-4_11","volume":"1097","author":"BM Fu","year":"2018","unstructured":"Fu BM. Tumor Metastasis in the Microcirculation. Adv Exp Med Biol. 2018;1097:201\u201318.","journal-title":"Adv Exp Med Biol"},{"key":"1014_CR196","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s43556-025-00286-3","volume":"6","author":"L Jiao","year":"2025","unstructured":"Jiao L, Si Y, Yuan Y, Lei X, Jiang Q, Yang L, Mao W, Ying B, Ma L, Sun T. Emerging role of N-acetyltransferase 10 in diseases: RNA ac4C modification and beyond. Mol Biomed. 2025;6:46.","journal-title":"Mol Biomed"},{"key":"1014_CR197","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s13046-025-03591-5","volume":"44","author":"T Wang","year":"2025","unstructured":"Wang T, Ma X, Wang Y, Liu H, Ding G, Li Y, Yuan H, Gao J, Sun F, Guo Y, et al. Lactate-driven lactylation of HNRNPA1 orchestrates PKM2 splicing and glycolytic reprogramming in bladder cancer. J Exp Clin Cancer Res. 2025;44:331.","journal-title":"J Exp Clin Cancer Res"},{"key":"1014_CR198","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13045-025-01743-w","volume":"18","author":"Y Xu","year":"2025","unstructured":"Xu Y, Xie D, Cao C, Wang Z, Ju Y, Guan L, Li X, Wu S, Zhang L, Liang C, Yin X. PSMA-targeted CAR-macrophages drive glycolytic reprogramming for enhanced prostate cancer immunotherapy. J Hematol Oncol. 2025;18:95.","journal-title":"J Hematol Oncol"},{"key":"1014_CR199","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1097\/HEP.0000000000000455","volume":"78","author":"F Yang","year":"2023","unstructured":"Yang F, Hilakivi-Clarke L, Shaha A, Wang Y, Wang X, Deng Y, Lai J, Kang N. Metabolic reprogramming and its clinical implication for liver cancer. Hepatology. 2023;78:1602\u201324.","journal-title":"Hepatology"},{"key":"1014_CR200","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1158\/0008-5472.CAN-24-3173","volume":"85","author":"T Li","year":"2025","unstructured":"Li T, Hu C, Huang T, Zhou Y, Tian Q, Chen H, He R, Yuan Y, Jiang Y, Jiang H, et al. Cancer-Associated Fibroblasts Foster a High-Lactate Microenvironment to Drive Perineural Invasion in Pancreatic Cancer. Cancer Res. 2025;85:2199\u2013217.","journal-title":"Cancer Res"},{"key":"1014_CR201","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1566523222666220830150446","volume":"23","author":"Y Li","year":"2023","unstructured":"Li Y, Huang H, Wu S, Zhou Y, Huang T, Jiang J. The Role of RNA m(6)A Modification in Cancer Glycolytic Reprogramming. Curr Gene Ther. 2023;23:51\u20139.","journal-title":"Curr Gene Ther"},{"key":"1014_CR202","doi-asserted-by":"publisher","first-page":"112441","DOI":"10.1016\/j.cellsig.2026.112441","volume":"143","author":"T Wang","year":"2026","unstructured":"Wang T, Zhen J, Wei Q, Ji R, Liu G, Lin S, Lu J, Wang Q. GNE-493 suppresses gastric cancer development by targeting NAT10-mediated ac4C modification of HK2. Cell Signal. 2026;143:112441.","journal-title":"Cell Signal"},{"key":"1014_CR203","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s12964-024-01760-1","volume":"22","author":"X Liu","year":"2024","unstructured":"Liu X, Ren B, Ren J, Gu M, You L, Zhao Y. The significant role of amino acid metabolic reprogramming in cancer. Cell Commun Signal. 2024;22:380.","journal-title":"Cell Commun Signal"},{"key":"1014_CR204","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","volume":"23","author":"S Liu","year":"2024","unstructured":"Liu S, Zhang X, Wang W, Li X, Sun X, Zhao Y, Wang Q, Li Y, Hu F, Ren H. Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer. Mol Cancer. 2024;23:261.","journal-title":"Mol Cancer"},{"key":"1014_CR205","doi-asserted-by":"publisher","first-page":"44","DOI":"10.20892\/j.issn.2095-3941.2019.0210","volume":"17","author":"Z Wang","year":"2020","unstructured":"Wang Z, Jiang Q, Dong C. Metabolic reprogramming in triple-negative breast cancer. Cancer Biol Med. 2020;17:44\u201359.","journal-title":"Cancer Biol Med"},{"key":"1014_CR206","doi-asserted-by":"crossref","unstructured":"Hanada K, Kawada K, Obama K. Targeting asparagine metabolism in solid tumors. Nutrients. 2025;17.","DOI":"10.3390\/nu17010179"},{"key":"1014_CR207","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41556-026-01905-z","volume":"28","author":"T Tao","year":"2026","unstructured":"Tao T, Feng X, Yang Y, Liu B, Liang J, Chen Z, Wang S, Zhao J, Yang X, Huo L, et al. The lncRNA DAMER selectively guides m(6)A-dependent regulation of ATF4 and asparagine metabolism under nutrient stress in cancer. Nat Cell Biol. 2026;28:797\u2013811.","journal-title":"Nat Cell Biol"},{"key":"1014_CR208","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41591-019-0404-8","volume":"25","author":"H Li","year":"2019","unstructured":"Li H, Ning S, Ghandi M, Kryukov GV, Gopal S, Deik A, Souza A, Pierce K, Keskula P, Hernandez D, et al. The landscape of cancer cell line metabolism. Nat Med. 2019;25:850\u201360.","journal-title":"Nat Med"},{"key":"1014_CR209","doi-asserted-by":"publisher","first-page":"1603032","DOI":"10.3389\/fimmu.2025.1603032","volume":"16","author":"W Liu","year":"2025","unstructured":"Liu W, Dong S, Hao F, Gao Y, Wei Q. Lipid metabolic reprogramming in colorectal cancer: mechanisms and therapeutic strategies. Front Immunol. 2025;16:1603032.","journal-title":"Front Immunol"},{"key":"1014_CR210","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.7150\/ijbs.105391","volume":"21","author":"J Li","year":"2025","unstructured":"Li J, Luo Q, Lu M, Lu C, Xu C, Ding J, Zhan T, Zhu J, Qian M, Lin S, et al. METTL16 Promotes Lipid Metabolic Reprogramming and Colorectal Cancer Progression. Int J Biol Sci. 2025;21:4782\u201397.","journal-title":"Int J Biol Sci"},{"key":"1014_CR211","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s12964-024-01792-7","volume":"22","author":"X Wang","year":"2024","unstructured":"Wang X, Li Y, Hou X, Li J, Ma X. Lipid metabolism reprogramming in endometrial cancer: biological functions and therapeutic implications. Cell Commun Signal. 2024;22:436.","journal-title":"Cell Commun Signal"},{"key":"1014_CR212","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1002\/jcb.30155","volume":"122","author":"MH Dalhat","year":"2021","unstructured":"Dalhat MH, Mohammed MRS, Ahmad A, Khan MI, Choudhry H. Remodelin, a N-acetyltransferase 10 (NAT10) inhibitor, alters mitochondrial lipid metabolism in cancer cells. J Cell Biochem. 2021;122:1936\u201345.","journal-title":"J Cell Biochem"},{"key":"1014_CR213","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","volume":"80","author":"JN Moloney","year":"2018","unstructured":"Moloney JN, Cotter TG. ROS signalling in the biology of cancer. Semin Cell Dev Biol. 2018;80:50\u201364.","journal-title":"Semin Cell Dev Biol"},{"key":"1014_CR214","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-022-01304-4","volume":"8","author":"L Yang","year":"2023","unstructured":"Yang L, Li A, Wang Y, Zhang Y. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal Transduct Target Ther. 2023;8:35.","journal-title":"Signal Transduct Target Ther"},{"key":"1014_CR215","doi-asserted-by":"crossref","unstructured":"Dalhat MH, Choudhry H, Khan MI. NAT10, an RNA cytidine acetyltransferase, regulates ferroptosis in cancer cells. Antioxid (Basel). 2023;12.","DOI":"10.3390\/antiox12051116"},{"key":"1014_CR216","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10495-021-01682-0","volume":"26","author":"X Dai","year":"2021","unstructured":"Dai X, Wang D, Zhang J. Programmed cell death, redox imbalance, and cancer therapeutics. Apoptosis. 2021;26:385\u2013414.","journal-title":"Apoptosis"},{"key":"1014_CR217","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng F, Liao M, Qin R, Zhu S, Peng C, Fu L, Chen Y, Han B. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Ther. 2022;7:286.","journal-title":"Signal Transduct Target Ther"},{"key":"1014_CR218","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/s42003-022-03868-x","volume":"5","author":"H Zhang","year":"2022","unstructured":"Zhang H, Chen Z, Zhou J, Gu J, Wu H, Jiang Y, Gao S, Liao Y, Shen R, Miao C, Chen W. NAT10 regulates neutrophil pyroptosis in sepsis via acetylating ULK1 RNA and activating STING pathway. Commun Biol. 2022;5:916.","journal-title":"Commun Biol"},{"key":"1014_CR219","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41571-024-00876-0","volume":"21","author":"D Tang","year":"2024","unstructured":"Tang D, Kroemer G, Kang R. Targeting cuproplasia and cuproptosis in cancer. Nat Rev Clin Oncol. 2024;21:370\u201388.","journal-title":"Nat Rev Clin Oncol"},{"key":"1014_CR220","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-025-02192-0","volume":"10","author":"Z Guo","year":"2025","unstructured":"Guo Z, Chen D, Yao L, Sun Y, Li D, Le J, Dian Y, Zeng F, Chen X, Deng G. The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer. Signal Transduct Target Ther. 2025;10:149.","journal-title":"Signal Transduct Target Ther"},{"key":"1014_CR221","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/procel\/pwae003","volume":"15","author":"C Mao","year":"2024","unstructured":"Mao C, Wang M, Zhuang L, Gan B. Metabolic cell death in cancer: ferroptosis, cuproptosis, disulfidptosis, and beyond. Protein Cell. 2024;15:642\u201360.","journal-title":"Protein Cell"},{"key":"1014_CR222","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12943-020-1138-4","volume":"19","author":"X Li","year":"2020","unstructured":"Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer. 2020;19:12.","journal-title":"Mol Cancer"},{"key":"1014_CR223","doi-asserted-by":"publisher","first-page":"101170","DOI":"10.1016\/j.drup.2024.101170","volume":"78","author":"X Niu","year":"2025","unstructured":"Niu X, You Q, Hou K, Tian Y, Wei P, Zhu Y, Gao B, Ashrafizadeh M, Aref AR, Kalbasi A, et al. Autophagy in cancer development, immune evasion, and drug resistance. Drug Resist Updat. 2025;78:101170.","journal-title":"Drug Resist Updat"},{"key":"1014_CR224","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12943-024-01934-y","volume":"23","author":"J Liu","year":"2024","unstructured":"Liu J, Wu Y, Meng S, Xu P, Li S, Li Y, Hu X, Ouyang L, Wang G. Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives. Mol Cancer. 2024;23:22.","journal-title":"Mol Cancer"},{"key":"1014_CR225","doi-asserted-by":"publisher","first-page":"9601","DOI":"10.1093\/nar\/gky777","volume":"46","author":"X Liu","year":"2018","unstructured":"Liu X, Cai S, Zhang C, Liu Z, Luo J, Xing B, Du X. Deacetylation of NAT10 by Sirt1 promotes the transition from rRNA biogenesis to autophagy upon energy stress. Nucleic Acids Res. 2018;46:9601\u201316.","journal-title":"Nucleic Acids Res"},{"key":"1014_CR226","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","volume":"20","author":"I Barbieri","year":"2020","unstructured":"Barbieri I, Kouzarides T. Role of RNA modifications in cancer. Nat Rev Cancer. 2020;20:303\u201322.","journal-title":"Nat Rev Cancer"},{"key":"1014_CR227","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1080\/15476286.2020.1722449","volume":"17","author":"P Haruehanroengra","year":"2020","unstructured":"Haruehanroengra P, Zheng YY, Zhou Y, Huang Y, Sheng J. RNA modifications and cancer. RNA Biol. 2020;17:1560\u201375.","journal-title":"RNA Biol"},{"key":"1014_CR228","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1158\/0008-5472.CAN-23-4062","volume":"84","author":"S Liu","year":"2024","unstructured":"Liu S, Lin C, Lin X, Lin P, He R, Pan X, Lin Y, Ye J, Zhu G. NAT10 Phase Separation Regulates YTHDF1 Splicing to Promote Gastric Cancer Progression. Cancer Res. 2024;84:3207\u201322.","journal-title":"Cancer Res"},{"key":"1014_CR229","doi-asserted-by":"publisher","first-page":"152223","DOI":"10.1016\/j.ijbiomac.2026.152223","volume":"365","author":"Q Gao","year":"2026","unstructured":"Gao Q, Qiu L, Xiao M, Li RF, Wang J, Ge XY. MYB-driven NAT10-IGF2BP3 RNA modification axis sustains MAPK signaling and promotes adenoid cystic carcinoma progression. Int J Biol Macromol. 2026;365:152223.","journal-title":"Int J Biol Macromol"},{"key":"1014_CR230","doi-asserted-by":"publisher","first-page":"117618","DOI":"10.1016\/j.cca.2023.117618","volume":"551","author":"A Solati","year":"2023","unstructured":"Solati A, Thvimi S, Khatami SH, Shabaninejad Z, Malekzadegan Y, Alizadeh M, Mousavi P, Taheri-Anganeh M, Razmjoue D, Bahmyari S, et al. Non-coding RNAs in gynecologic cancer. Clin Chim Acta. 2023;551:117618.","journal-title":"Clin Chim Acta"},{"key":"1014_CR231","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1042\/EBC20200032","volume":"65","author":"H Yan","year":"2021","unstructured":"Yan H, Bu P. Non-coding RNA in cancer. Essays Biochem. 2021;65:625\u201339.","journal-title":"Essays Biochem"},{"key":"1014_CR232","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1515\/med-2022-0583","volume":"17","author":"C Du","year":"2022","unstructured":"Du C, Han X, Zhang Y, Guo F, Yuan H, Wang F, Li M, Ning F, Wang W. DARS-AS1 modulates cell proliferation and migration of gastric cancer cells by regulating miR-330-3p\/NAT10 axis. Open Med (Wars). 2022;17:2036\u201345.","journal-title":"Open Med (Wars)"},{"key":"1014_CR233","doi-asserted-by":"crossref","unstructured":"Yang J, Li C, Yin W, Fang F, Zhao Z. Oncogenic role of LncRNA DLEU2 in thyroid cancer through a NAT10\/USP39 regulatory axis. Mamm Genome. 2026;37.","DOI":"10.1007\/s00335-026-10225-4"},{"key":"1014_CR234","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s13353-024-00840-9","volume":"65","author":"S Wang","year":"2024","unstructured":"Wang S, Li Q, Wang Y, Li X, Feng X, Wei Y, Wang J, Zhou X. Peptidylprolyl isomerase D circular RNA sensitizes breast cancer to trastuzumab through remodeling HER2 N4-acetylcytidine modification. J Appl Genet. 2024;65:797\u2013807.","journal-title":"J Appl Genet"},{"key":"1014_CR235","doi-asserted-by":"crossref","unstructured":"Lv F, Zhao Q, Zou R, Ye X, Shen Y, Meng L, Guo J, Wang Y, Zheng Y, Liu Y, et al. Targeted delivery of TGF-\u03b2 inhibitor via LHRH-NanoTi reverses the NAT10\/ac4C-mediated cisplatin-induced immunosuppressive tumor microenvironment in ovarian cancer. J Nanobiotechnol. 2026.","DOI":"10.1186\/s12951-026-04631-8"},{"key":"1014_CR236","doi-asserted-by":"crossref","unstructured":"Li M, Zhao X, Wu J, Zhou S, Fu Y, Chen C, Ma Z, Xu J, Qian Y, Wang Z, et al. Targeting the N-acetyltransferase 10\/DKK2 axis enhances CD8\u2009+\u2009T cell antitumor activity in colorectal cancer models. J Clin Invest. 2026;136.","DOI":"10.1172\/JCI196722"},{"key":"1014_CR237","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41419-025-08156-0","volume":"16","author":"L Wang","year":"2025","unstructured":"Wang L, Chen E, Zhang S, Xiang W, Ye H, Fu Y, Xu S, Wang Q, Tao Y, Yang D, et al. Targeting the ac4C \u2018Writer\u2019 NAT10 enhances pancreatic cancer immunotherapy via dual modulation of CD8\u2009+\u2009T cells and tumor cells. Cell Death Dis. 2025;16:809.","journal-title":"Cell Death Dis"},{"key":"1014_CR238","doi-asserted-by":"crossref","unstructured":"Hu X, Feng M, Qi C, Li B, He H, Li K, Chen L, Ji B, Yu H, Zhao Y, et al. NAT10-mediated ac4C RNA acetylation stabilizes CXCL5\/DEK mRNA to drive proliferation and metastasis in lung adenocarcinoma. Cell Death Dis. 2026;17.","DOI":"10.1038\/s41419-026-08568-6"},{"key":"1014_CR239","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41419-025-07796-6","volume":"16","author":"Z Xiao","year":"2025","unstructured":"Xiao Z, Wei X, Li P, Chen R, Yu Z, Liang Y, Su Y, Ge J. Impact of N-acetyltransferase 10 on macrophage activation and inflammation-induced cardiac dysfunction. Cell Death Dis. 2025;16:471.","journal-title":"Cell Death Dis"},{"key":"1014_CR240","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41420-024-01997-2","volume":"10","author":"Z Wang","year":"2024","unstructured":"Wang Z, Luo J, Huang H, Wang L, Lv T, Wang Z, Li C, Wang Y, Liu J, Cheng Q, et al. NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53\/IRF1\/type I interferon signaling axis. Cell Death Discov. 2024;10:240.","journal-title":"Cell Death Discov"},{"key":"1014_CR241","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13046-025-03638-7","volume":"45","author":"X Ma","year":"2026","unstructured":"Ma X, Jin S, Zhang X, Zhao L, Wang H, Liu S, Li H, Wang Q, Gao S, Wang J, et al. Targeting the NAT10-HDAC4 positive feedback loop counteracts immunosuppression in breast cancer. J Exp Clin Cancer Res. 2026;45:35.","journal-title":"J Exp Clin Cancer Res"},{"key":"1014_CR242","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s10020-024-00780-4","volume":"30","author":"G Qin","year":"2024","unstructured":"Qin G, Bai F, Hu H, Zhang J, Zhan W, Wu Z, Li J, Fu Y, Deng Y. Targeting the NAT10\/NPM1 axis abrogates PD-L1 expression and improves the response to immune checkpoint blockade therapy. Mol Med. 2024;30:13.","journal-title":"Mol Med"},{"key":"1014_CR243","doi-asserted-by":"crossref","unstructured":"Qian L, Gao W, Wang X, Cui S, Han X, Xu X, Jia J, Liu Z. NAT10 promotes cisplatin resistance and immune escape by increasing the expression of DUSP1 and PD-L1 in gastric cancer. Cell Death Discov. 2026;12.","DOI":"10.1038\/s41420-026-03107-w"},{"key":"1014_CR244","doi-asserted-by":"publisher","first-page":"100658","DOI":"10.1016\/j.clinsp.2025.100658","volume":"80","author":"Z Wang","year":"2025","unstructured":"Wang Z, Yin M, Zhou R, Li M, Peng J, Wang Z. Kynurenine promotes the immune escape of colorectal cancer cells via NAT10-mediated ac(4)C acetylation of PD-L1. Clin (Sao Paulo). 2025;80:100658.","journal-title":"Clin (Sao Paulo)"},{"key":"1014_CR245","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.2215\/CJN.15040920","volume":"16","author":"D Wojciechowski","year":"2021","unstructured":"Wojciechowski D, Wiseman A. Long-Term Immunosuppression Management: Opportunities and Uncertainties. Clin J Am Soc Nephrol. 2021;16:1264\u201371.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1014_CR246","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1136\/gutjnl-2022-328845","volume":"72","author":"Y Bao","year":"2023","unstructured":"Bao Y, Zhai J, Chen H, Wong CC, Liang C, Ding Y, Huang D, Gou H, Chen D, Pan Y, et al. Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer. Gut. 2023;72:1497\u2013509.","journal-title":"Gut"},{"key":"1014_CR247","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1093\/neuonc\/noae268","volume":"27","author":"J Qiu","year":"2025","unstructured":"Qiu J, Zhao R, Ma C, Wang Q, Li B, Qi Y, Pan Z, Zhao S, Wang S, Gao Z, et al. O-GlcNAcylation stabilized WTAP promotes GBM malignant progression in an N6-methyladenosine-dependent manner. Neuro Oncol. 2025;27:900\u201315.","journal-title":"Neuro Oncol"},{"key":"1014_CR248","doi-asserted-by":"publisher","first-page":"146767","DOI":"10.1016\/j.ijbiomac.2025.146767","volume":"322","author":"D Yang","year":"2025","unstructured":"Yang D, Yun Y, Ma Y, Gao Y, Ou Y, Zhao C, Zhou X. Integrative multi-omics analysis N4-acetylcytidine modification landscape and the role of TMEM65 in breast cancer. Int J Biol Macromol. 2025;322:146767.","journal-title":"Int J Biol Macromol"},{"key":"1014_CR249","doi-asserted-by":"publisher","first-page":"e2418409122","DOI":"10.1073\/pnas.2418409122","volume":"122","author":"JN Wang","year":"2025","unstructured":"Wang JN, Suo XG, Yu JT, Luo QC, Ji ML, Zhang MM, Zhu Q, Cheng XR, Hou C, Chen X, et al. NAT10 exacerbates acute renal inflammation by enhancing N4-acetylcytidine modification of the CCL2\/CXCL1 axis. Proc Natl Acad Sci U S A. 2025;122:e2418409122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1014_CR250","doi-asserted-by":"publisher","first-page":"113365","DOI":"10.1016\/j.intimp.2024.113365","volume":"143","author":"M Arafat Hossain","year":"2024","unstructured":"Arafat Hossain M. A comprehensive review of immune checkpoint inhibitors for cancer treatment. Int Immunopharmacol. 2024;143:113365.","journal-title":"Int Immunopharmacol"},{"key":"1014_CR251","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/curroncol29050247","volume":"29","author":"Y Shiravand","year":"2022","unstructured":"Shiravand Y, Khodadadi F, Kashani SMA, Hosseini-Fard SR, Hosseini S, Sadeghirad H, Ladwa R, O\u2019Byrne K, Kulasinghe A. Immune Checkpoint Inhibitors in Cancer Therapy. Curr Oncol. 2022;29:3044\u201360.","journal-title":"Curr Oncol"},{"key":"1014_CR252","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1038\/s41388-024-03185-z","volume":"43","author":"Y Liu","year":"2024","unstructured":"Liu Y, Li J, Xu J, Long Y, Wang Y, Liu X, Hu J, Wei Q, Luo Q, Luo F, et al. m(6)A-driven NAT10 translation facilitates fatty acid metabolic rewiring to suppress ferroptosis and promote ovarian tumorigenesis through enhancing ACOT7 mRNA acetylation. Oncogene. 2024;43:3498\u2013516.","journal-title":"Oncogene"},{"key":"1014_CR253","doi-asserted-by":"publisher","first-page":"2610551","DOI":"10.1080\/09513590.2025.2610551","volume":"42","author":"Y Pan","year":"2026","unstructured":"Pan Y, Zhang Y, Teng X, Zhang Y. Role of NAT10-mediated RNA acetylation in premature ovarian insufficiency: a mechanistic review. Gynecol Endocrinol. 2026;42:2610551.","journal-title":"Gynecol Endocrinol"},{"key":"1014_CR254","doi-asserted-by":"publisher","first-page":"1777527","DOI":"10.3389\/fimmu.2026.1777527","volume":"17","author":"S Li","year":"2026","unstructured":"Li S, Fang Y, Fan Y, Niu H, Sun X, Xue Z, Ling R, Hua Y, Tang X. NAT10: a potential factor to reverse tumor chemotherapy resistance and radioresistance (Review). Front Immunol. 2026;17:1777527.","journal-title":"Front Immunol"},{"key":"1014_CR255","doi-asserted-by":"publisher","first-page":"1845155","DOI":"10.3389\/fimmu.2026.1845155","volume":"17","author":"W Bo","year":"2026","unstructured":"Bo W, Yi Y, Zhao B, Dong H. NAT10 as a central node in cancer biology: integrating epitranscriptomic regulation, metabolic reprogramming, and immune modulation. Front Immunol. 2026;17:1845155.","journal-title":"Front Immunol"},{"key":"1014_CR256","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.1039\/D3NR06059D","volume":"16","author":"J Zhong","year":"2024","unstructured":"Zhong J, Zhao R, Wang Y, Su YX, Lan X. Nano-PROTACs: state of the art and perspectives. Nanoscale. 2024;16:4378\u201391.","journal-title":"Nanoscale"},{"key":"1014_CR257","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1021\/acscentsci.5c00812","volume":"11","author":"K Ao","year":"2025","unstructured":"Ao K, Sun Z, Hao Y, Qin J, Xu C, Wen X, Yang Z, Li L, Gan S, Chen X, et al. Targeted NAT10 Degradation by PROTAC NP1192 Suppresses Hypoxia-Adaptive Glycolysis and Reinvigorates CD8(+) Effector T\u2013Cell Function for Synergistic Cancer Immunotherapy. ACS Cent Sci. 2025;11:2087\u2013107.","journal-title":"ACS Cent Sci"},{"key":"1014_CR258","doi-asserted-by":"publisher","first-page":"e70711","DOI":"10.1002\/ctm2.70711","volume":"16","author":"W Wei","year":"2026","unstructured":"Wei W, Jiang C, Zhu D, Han X, Ma X, Jia X, Ling J, Zhang R, Li F, Yin N. NAT10-mediated N4-acetylcytidine modification drives RNA splicing of PML to alleviate adipose-derived stem cell senescence and promote diabetic wound healing. Clin Transl Med. 2026;16:e70711.","journal-title":"Clin Transl Med"},{"key":"1014_CR259","doi-asserted-by":"crossref","unstructured":"Zhao Y. Targeting oncogenic acetyltransferase NAT10 to overcome anti-PD-1 resistance in nasopharyngeal carcinoma. J Immunother Cancer. 2025;13.","DOI":"10.1136\/jitc-2025-012254"},{"key":"1014_CR260","doi-asserted-by":"crossref","unstructured":"Yang Y, Chen C, Feng Y, Lv Q. NAT10 and ac4C modification in cancer immunity and metabolism: emerging mechanisms and therapeutic potential. J Transl Med. 2026;24.","DOI":"10.1186\/s12967-026-07788-w"},{"key":"1014_CR261","doi-asserted-by":"publisher","first-page":"1853392","DOI":"10.3389\/fphar.2026.1853392","volume":"17","author":"F Li","year":"2026","unstructured":"Li F, Deng W, Jiang X, Li Z. Targeting NAT10 with Remodelin in cancer drug resistance: mechanisms, preclinical evidence, and combination strategies. Front Pharmacol. 2026;17:1853392.","journal-title":"Front Pharmacol"},{"key":"1014_CR262","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13046-025-03362-2","volume":"44","author":"L Huang","year":"2025","unstructured":"Huang L, Lu Y, He R, Guo X, Zhou J, Fu Z, Li J, Liu J, Chen R, Zhou Y, Zhou Q. N(4)-acetylcytidine modification of ITGB5 mRNA mediated by NAT10 promotes perineural invasion in pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res. 2025;44:103.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-01014-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-026-01014-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-01014-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:02:36Z","timestamp":1791572556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40364-026-01014-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":262,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1014"],"URL":"https:\/\/doi.org\/10.1186\/s40364-026-01014-x","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"24 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"134"}}